Home Loan Servicing Solutions (HLSSF) 10-Q/A 18 Aug 14 2014 Q1 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	Apr. 17, 2014
Document And Entity Information [Abstract]	'	'
Entity Registrant Name	'HOME LOAN SERVICING SOLUTIONS, LTD.	'
Trading Symbol	'HLSS	'
Entity Central Index Key	'0001513161	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Amendment Flag	'true	'
Entity Common Stock, Shares Outstanding	'	71,016,771
Amendment Description	'Home Loan Servicing Solutions, Ltd. (collectively referred to throughout as “HLSS”, “us”, “our”, “we”, or the “Company”) filed our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2014, (the “Original Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on April 17, 2014. We are filing this Amendment No. 1 to the Form 10-Q (the “Form 10-Q/A”) to properly state the Notes receivable - Rights to MSRs at fair value as of March 31, 2014 and December 31, 2013, and to include the effect of such fair value adjustments in the application of the interest method of accounting in the quarterly periods March 31, 2014 and 2013. Concurrently with the filing of this Form 10-Q/A, we are also filing an amendment to our Annual Report on Form 10-K for the year ended December 31, 2013 (the "Original Form 10-K"), filed with the SEC on February 6, 2014 on our Amendment No. 1 to Form 10-K/A (the “Form 10-K/A”, collectively with the Form 10-Q/A, the "Amendments").	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Cash and cash equivalents	$75,920	$87,896
Match funded advances	6,343,397	6,387,781
Notes receivable – Rights to MSRs	637,794	633,769
Loans held for investment	552,644	0
Related party receivables	67,599	70,049
Deferred tax assets	1,024	1,024
Other assets	192,769	130,153
Total assets	7,871,147	7,310,672
Liabilities	'	'
Match funded liabilities	5,775,180	5,715,622
Other borrowings	815,431	343,386
Dividends payable	10,653	10,653
Income taxes payable	600	682
Deferred tax liabilities	1,188	1,266
Related party payables	7,885	10,732
Other liabilities	11,510	11,884
Total liabilities	6,622,447	6,094,225
Commitments and Contingencies (See Note 15)	'	'
Equity	'	'
Equity – Ordinary shares, $.01 par value; 200,000,000 shares authorized; 71,016,771 and 71,016,771 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	710	710
Additional paid-in capital	1,210,057	1,210,057
Retained earnings	35,915	3,513
Accumulated other comprehensive income, net of tax	2,018	2,167
Total equity	1,248,700	1,216,447
Total liabilities and equity	$7,871,147	$7,310,672

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, Par value	$0.01	$0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	71,016,771	71,016,771
Common stock, shares outstanding	71,016,771	71,016,771

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenue	'	'
Interest income – notes receivable – Rights to MSRs	$102,538	$47,867
Interest income – other	2,961	102
Total interest income	105,499	47,969
Related party revenue	628	407
Total revenue	106,127	48,376
Operating expenses	'	'
Compensation and benefits	1,599	1,166
Related party expenses	372	226
General and administrative expenses	2,285	645
Total operating expenses	4,256	2,037
Income from operations	101,871	46,339
Other expense	'	'
Interest expense	37,511	18,242
Total other expense	37,511	18,242
Income before income taxes	64,360	28,097
Income tax expense	0	12
Net income	$64,360	$28,085
Earnings per share	'	'
Basic (usd per share)	$0.91	$0.50
Diluted (usd per share)	$0.91	$0.50
Weighted average shares outstanding	'	'
Basic (shares)	71,016,771	56,628,828
Diluted (shares)	71,016,771	56,628,828
Dividends declared per share	$0.45	$0.38

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Statement of Comprehensive Income [Abstract]	'	'
Net income	$64,360	$28,085
Other comprehensive income (loss), before tax:	'	'
Change in the value of designated cash flow hedges	-227	13
Total other comprehensive income (loss), before tax	-227	13
Income tax related to items of other comprehensive income (loss):	'	'
Tax benefit (expense) on change in the value of designated cash flow hedges	78	0
Total income tax benefit (expense) related to items of other comprehensive income (loss)	78	0
Total other comprehensive income (loss), net of tax	-149	13
Total comprehensive income	$64,211	$28,098

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Changes in Equity (USD $)	Total	Ordinary Shares	Additional Paid-in Capital	Retained Earnings (Restated)	Accumulated Other Comprehensive Income (Loss), net of tax
In Thousands, except Share data, unless otherwise specified
Balance at Dec. 31, 2012	$873,379	$559	$876,657	($2,761)	($1,076)
Balance (in shares) at Dec. 31, 2012	'	55,884,718	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Net income	28,085	'	'	28,085	'
Other comprehensive loss, net of tax	13	'	'	'	13
Issuance of ordinary shares, net of costs (in shares)	970,578	970,578	'	'	'
Issuance of ordinary shares, net of costs	17,579	10	17,569	'	'
Declaration of cash dividends	-21,605	'	0	-21,605	'
Balance at Mar. 31, 2013	897,451	569	894,226	3,719	-1,063
Balance (in shares) at Mar. 31, 2013	'	56,855,296	'	'	'
Balance at Dec. 31, 2013	1,216,447	710	1,210,057	3,513	2,167
Balance (in shares) at Dec. 31, 2013	'	71,016,771	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Net income	64,360	'	'	64,360	'
Other comprehensive loss, net of tax	-149	'	'	'	-149
Issuance of ordinary shares, net of costs (in shares)	0	0	'	'	'
Issuance of ordinary shares, net of costs	0	0	0	'	'
Declaration of cash dividends	-31,958	'	0	-31,958	'
Balance at Mar. 31, 2014	$1,248,700	$710	$1,210,057	$35,915	$2,018
Balance (in shares) at Mar. 31, 2014	'	71,016,771	'	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Changes in Equity (Parenthetical) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statement of Stockholders' Equity [Abstract]	'	'
Declaration of cash dividends, per share	$0.45	$0.38

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities	'	'
Net income	$64,360	$28,085
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Amortization of debt issuance costs	4,962	3,106
Accretion of original issue discount on other borrowings	185	0
Reduction of purchase premium on loans held for investment	448	0
Increase in the fair value of Notes receivable – Rights to MSRs	-4,025	0
Changes in assets and liabilities:	'	'
Decrease in match funded advances	44,384	277,141
Decrease (increase) in debt service accounts	-3,077	5,498
Decrease in related party receivables	2,450	24,292
(Decrease) increase in related party payables	-2,847	32,076
(Increase) in other assets	-2,645	-382
(Decrease) increase in other liabilities	-428	575
Net cash provided by operating activities	103,767	370,391
Cash flows from investing activities	'	'
Purchase of notes receivable – Rights to MSRs	0	-100,737
Reduction in notes receivable – Rights to MSRs	0	7,339
Purchase of loans held for investment	-556,618	0
Proceeds from loans held for investment	3,526	0
Cash used in advance financing receivables transaction	-55,702	0
Acquisition of advances in connection with the purchase of residential mortgage assets	0	-713,582
Net cash used in investing activities	-608,794	-806,980
Cash flows from financing activities	'	'
Proceeds from match funded liabilities, net	59,558	430,043
Proceeds from other borrowings	472,734	0
Payment of other borrowings	-875	0
Payment of debt issuance costs	-6,408	-5,036
Proceeds from issuance of ordinary shares	0	17,633
Payment of offering costs	0	-22
Payment of dividends to shareholders	-31,958	-20,920
Net cash provided by financing activities	493,051	421,698
Net (decrease) in cash	-11,976	-14,891
Cash at beginning of period	87,896	76,048
Cash at end of period	75,920	61,157
Supplemental non-cash financing activities	'	'
Dividends declared but not paid	10,653	7,391
Offering costs accrued but not paid	0	32
Debt issuance costs accrued but not paid	$58	$309

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization
	Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries (collectively referred to throughout as “HLSS”, “us”, “our”, “we” or the “Company”) focus on acquiring residential mortgage assets.
	Basis of Presentation and Use of Estimates
	We prepared the accompanying unaudited Interim Condensed Consolidated Financial Statements in conformity with the instructions of the Securities and Exchange Commission (“SEC”) to Form 10-Q for interim financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. Material estimates that are particularly significant relate to our fair value measurements of Notes receivable – Rights to MSRs.
	Principles of Consolidation
	Our financial statements include the accounts of Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries, as well as three variable interest entities (“VIE”) of which we are the primary beneficiary. We eliminate intercompany accounts and transactions in consolidation.
	We evaluate each special purpose entity (“SPE”) for classification as a VIE. When a SPE meets the definition of a VIE and we determine that HLSS is the primary beneficiary, we include the SPE in our Interim Condensed Consolidated Financial Statements.
	Our Match funded advances are in two SPEs along with related Match funded liabilities. We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Match funded advances on loans serviced for others result from our transfers of residential loan servicing advances to SPEs in exchange for cash. The SPEs issue debt supported by collections on the transferred advances. We made these transfers under the terms of our advance facility agreements. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred advances on our Interim Condensed Consolidated Balance Sheet as Match funded advances and the related liabilities as Match funded liabilities. We use collections on the Match funded advances pledged to the SPEs to repay principal and to pay interest and the expenses of the entity. Holders of the debt issued by this entity can look only to the assets of the entity itself for satisfaction of the debt and have no recourse against HLSS.
	On March 3, 2014, we acquired Government National Mortgage Association (“GNMA”) loans from Ocwen with an unpaid principal balance (“UPB”) of $549,411. Ocwen initially acquired these loans through the GNMA early buy-out (“EBO”) program which allows servicers of GNMA insured loans to buy delinquent loans from the applicable loan securitization pools. We account for these GNMA EBO loans as “Loans held for investment,” as described more fully later in this footnote. We also financed the GNMA EBO advances related to the GNMA EBO loans, and we account for this arrangement as a financing transaction because Ocwen retained title and all other rights and rewards associated with the GNMA EBO advances. Collectively, the purchase of GNMA EBO loans and financing of the related advances are referred to as the “GNMA EBO Transaction.” Our GNMA EBO loans are in a SPE with a related financing facility ("Mortgage Loan Facility"). The accounts of this SPE are included in our Interim Condensed Consolidated Financial Statements. These transfers to the SPE do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred GNMA EBO loans on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the GNMA EBO loans pledged to the SPE to repay principal and to pay interest and the expenses of the entity. The holders of the debt issued by this SPE can look beyond the assets of the SPE for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that since our GNMA EBO loans are insured by the Federal Housing Administration (“FHA”), the cash flows of this SPE will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPE.
	The following tables summarize the assets and liabilities of our consolidated SPEs, at the dates indicated:
	At March 31, 2014		Match Funded Advance SPEs		Mortgage Loans SPE		Total
	Match funded advances		$	6,343,397	$	—	$	6,343,397
	Loans held for investment		—		552,644		552,644
	Related party receivables (1)		56,655		—		56,655
	Other assets (2)		120,980		61,662		182,642
	Total assets		$	6,521,032	$	614,306	$	7,135,338
	Match funded liabilities		$	5,775,180	$	—	$	5,775,180
	Other borrowings(3)		—		472,734		472,734
	Other liabilities		4,525		1,220		5,745
	Total liabilities		$	5,779,705	$	473,954	$	6,253,659
	At December 31, 2013		Match Funded Advance SPEs		Mortgage Loans SPE		Total
	Match funded advances		$	6,387,781	$	—	$	6,387,781
	Loans held for investment		—		—		—
	Related party receivables (1)		60,239		—		60,239
	Other assets (2)		119,902		—		119,902
	Total assets		$	6,567,922	$	—	$	6,567,922
	Match funded liabilities		$	5,715,622	$	—	$	5,715,622
	Other borrowings(3)		—		—		—
	Other liabilities		4,673		—		4,673
	Total liabilities		$	5,720,295	$	—	$	5,720,295
	-1	Related party receivables principally includes Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 14 for more information about our Related party receivables.
	-2	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of the GNMA EBO Transaction. See Note 5 for more information about our Other assets.
	-3	Other borrowings include the carrying value of our Mortgage Loan Facility. See Note 7 for more information about our Other borrowings.
	Loans Held for Investment and Related Accrued Income
	We account for our GNMA EBO loans under ASC 310-20, Receivables – Nonrefundable Fees and Other Costs. In accordance with ASC 310-20 30-5, these loans are recorded at the UPB plus a purchase premium which is the amount we paid to purchase these loans. The purchase premium is amortized into interest income using the interest method of accounting. These loans are FHA insured, making the collectability of the entire Loans held for investment balance reasonably assured. We evaluate whether all contractual payments will be collected as scheduled according to contractual terms. We incorporate the probable recovery of such payments due to FHA insurance in this analysis. Our Loans held for investment related to GNMA EBO loans are our only class of mortgage loans held for investment, and we evaluate these loans on a periodic basis to ensure a carrying value of the lower of cost or fair value. We had no loan impairments as of and for the period ended March 31, 2014.
	We accrue interest income on our GNMA EBO loans at the note rate specific to each individual GNMA EBO loan. We allow for doubtful receivables if we have concerns about the collectability of all or a portion of our accrued income. As of and for the period ended March 31, 2014, we did not have an allowance for accrued interest income related to our GNMA EBO loans. We periodically evaluate whether our GNMA EBO loans should be placed on non-accrual status. All of our GNMA EBO loans remained on accrual status for the period ended March 31, 2014.
	Recent Accounting Pronouncements
	Accounting Standards Update (“ASU”) ASU 2013-11. This ASU provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit exists. Previously, there was diversity in practice, and this ASU is expected to eliminate that diversity in practice. The amendments in this update are effective for fiscal years, and interim periods within those years ended beginning after December 15, 2013. Our adoption of this standard effective January 1, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-06. This ASU provides technical corrections and improvements to Accounting Standards Codification glossary terms. Our adoption of this standard, effective March 14, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	Certain disclosures included in the Company’s Annual Report are not required to be included on an interim basis in the Company’s Quarterly Reports on Forms 10-Q. The Company has condensed or omitted these disclosures. Therefore, this Form 10-Q/A should be read in conjunction with the Company’s amended Annual Report on Form 10-K filed with the SEC on August 18, 2014 ("the Form 10-K/A").

Asset_Acquisitions

Asset Acquisitions	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Asset Acquisitions	'
	ASSET ACQUISITIONS
	We purchased assets from Ocwen on March 3, 2014 of GNMA EBO loans with UPB of $549,411. Because these loans earn interest at a rate that is higher than current market rates, the loans were purchased at a premium to par, resulting in a total purchase price of $556,618. We amortize the purchase price premium using the interest method of accounting. The following table summarizes the transaction and reconciles the cash used to acquire the GNMA EBO loans:
	GNMA EBO loans purchase price(1)	$	556,618
	Sources:
	Cash on-hand	$	83,884
	SPE financing	$	472,734
	-1	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.
	During the three months ended March 31, 2013, we executed our third flow purchase (“Flow 3”) wherein we used cash on-hand and Match funded liabilities to purchase the following:
	•	the contractual right to receive the servicing fees related to mortgage servicing rights with respect to 93 pooling and servicing agreements ("PSA") with UPB of approximately $15.9 billion which we account for as Notes receivable - Rights to MSRs; and
	•	the outstanding servicing advances associated with the related pooling and servicing agreements.
	The following table summarizes the purchase price of the assets we acquired from Ocwen during the three months ended March 31, 2013 and reconciles the cash used to acquire such assets:
	Notes receivable – Rights to MSRs	$	100,707
	Match funded advances (1)	$	703,206
	Purchase price, as adjusted	$	803,913
	Post-closing adjustments	$	10,406
	Total cash used	$	814,319
	Sources:
	Cash on-hand	$	153,142
	Match funded liabilities	$	661,177
	-1	The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of residential mortgage assets” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	FAIR VALUE OF FINANCIAL INSTRUMENTS
	We estimate fair value based on a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy prioritizes the inputs to valuation techniques into three broad levels and gives the highest priority to Level 1 inputs and the lowest to Level 3 inputs.
	The three broad categories are:
	•	Level 1: Quoted prices in active markets for identical assets or liabilities;
	•	Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
	•	Level 3: Unobservable inputs for the asset or liability.
	Where available, we utilize quoted market prices or observable inputs rather than unobservable inputs to determine fair value. We classify assets and liabilities in their entirety based on the lowest level of input that is significant to the fair value measurement.
	We describe the methodologies that we use and key assumptions that we make to assess the fair value of instruments in more detail below:
	Notes Receivable – Rights to MSRs
	We established the value of the Notes receivable – Rights to MSRs based on an appraisal prepared with the assistance of an independent valuation firm. This appraisal is prepared on a quarterly basis. Significant inputs into the valuation include the following:
	•	Discount rates reflecting the risk of earning the future income streams from the Notes receivable – Rights to MSRs ranging from 15% to 22%;
	•	Interest rate used for calculating the cost of servicing advances of 1-Month LIBOR plus 3.50%;
	•	Mortgage loan prepayment projections ranging from 12% to 28% of the related mortgage lifetime projected prepayment rate; and
	•	Delinquency rate projections ranging from 15% to 35% of the aggregate unpaid balance of the underlying mortgage loans.
	The independent valuation firm reviewed the collateral attributes and the historical payment performance of the underlying mortgage servicing portfolio and compared them with similar mortgage servicing portfolios and with standard industry mortgage performance benchmarks to arrive at the assumptions set forth above. The selected collateral attributes and performance comparisons utilized were the voluntary prepayment performance, delinquency and foreclosure performance, operational cost comparison, average loan balance, weighted average coupon and note rate distribution, loan product type classification, geographic distribution and servicing advance behavior.
	The unobservable inputs that have the most significant effect on the fair value of Notes receivable – Rights to MSRs are the mortgage loan prepayment rate projections and delinquency rate projections; however, any significant increase (decrease) in discount rates, interest rates, mortgage loan prepayment projections or delinquency rate projections, each in isolation, would result in a substantially lower (higher) valuation.
	Derivative Financial Instruments
	Our derivatives are not exchange-traded, and therefore quoted market prices or other observable inputs are not available. The fair value of our interest rate swap agreements is based on certain information provided by third-party pricing sources. Third-party valuations are derived from proprietary models based on inputs that include yield curves and contractual terms such as fixed interest rates and payment dates. We have not adjusted the information obtained from the third-party pricing sources; however, we review this information to ensure that it provides a reasonable basis for estimating fair value. Our review is designed to identify information that appears stale, information that has changed significantly from the prior period, and other indicators that the information may not be accurate. We determined that potential credit and counterparty risks had an immaterial impact on the valuation of our derivatives. See Note 9 for additional information on our derivative financial instruments.
	The following tables present reconciliations of the fair value and changes in fair value of our Level 3 assets and liabilities which we measure at fair value on a recurring basis:
	At March 31, 2014:		Fair value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	637,794			$	—			$	—			$	637,794
	Derivative financial instruments		3,523				—				—				3,523
	Total assets		$	641,317			$	—			$	—			$	641,317
	Liabilities:
	Derivative financial instruments		$	444			$	—			$	—			$	444
	Total liabilities		$	444			$	—			$	—			$	444
	At December 31, 2013:		Fair value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	633,769			$	—			$	—			$	633,769
	Derivative financial instruments		3,835				—				—				3,835
	Total assets		$	637,604			$	—			$	—			$	637,604
	Liabilities:
	Derivative financial instruments		$	529			$	—			$	—			$	529
	Total liabilities		$	529			$	—			$	—			$	529
			2014								2013
	For the three months ended March 31,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	633,769			$	3,306			$	296,451			$	(1,076	)
	Purchases and reductions:
	Purchases		—				—				100,707				—
	Reductions		—				—				(7,339		)		—
			$	—			$	—			$	93,368			$	—
	Changes in fair value :
	Included in net income (1)		4,025				—				—				—
	Included in other comprehensive income (2)		—				(227		)		—				13
			4,025				(227		)		—				13
	Transfers in or out of Level 3		—				—				—				—
	Ending balance		$	637,794			$	3,079			$	389,819			$	(1,063	)
	-1	Changes in fair value of the Notes receivable – Rights to MSRs are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 10 for additional information regarding our Interest income.
	-2	These pre-tax gains (losses) are attributable to derivatives still held at March 31, 2014 and March 31, 2013, respectively.
	The following table shows the effect on the fair value of the Notes receivable – Rights to MSRs assuming adverse changes to certain key assumptions used in valuing these assets at March 31, 2014 and December 31, 2013:
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At March 31, 2014:
	Notes receivable – Rights to MSRs	$	(12,936	)		$	(21,693	)		$	(71,773	)
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At December 31, 2013:
	Notes receivable – Rights to MSRs	$	(12,988	)		$	(22,537	)		$	(72,560	)
This sensitivity analysis above assumes a change is made to one key input, while holding all other inputs constant. As many of these inputs are correlated, a change in one input will likely impact other inputs which would ultimately impact the overall valuation.
The following table provides additional quantitative information on our significant inputs used for valuing our Notes receivable – Rights to MSRs as of March 31, 2014 and December 31, 2013, respectively:
At March 31, 2014:
Asset	Unobservable Input		Low			High			Weighted Average
Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		19	%
	Prepayment Speeds		12	%		28	%		18	%
	Delinquency Rates		15	%		35	%		24	%
At December 31, 2013:
Asset	Unobservable Input		Low			High			Weighted Average
Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		20	%
	Prepayment Speeds		12	%		28	%		19	%
	Delinquency Rates		15	%		35	%		25	%
Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value at the dates indicated:
	March 31, 2014				March 31, 2014				December 31, 2013				December 31, 2013
	Carrying Value				Fair Value				Carrying Value				Fair Value
Financial assets:
Match funded advances	$	6,343,397			$	6,343,397			$	6,387,781			$	6,387,781
Loans held for investment	552,644				552,644				—				—
Total financial assets	$	6,896,041			$	6,896,041			$	6,387,781			$	6,387,781
Financial liabilities:
Match funded liabilities	$	5,775,180			$	5,770,270			$	5,715,622			$	5,700,934
Other borrowings	815,431				817,144				343,386				346,391
Total financial liabilities	$	6,590,611			$	6,587,414			$	6,059,008			$	6,047,325
Match Funded Advances
The carrying value of our Match funded advances approximates fair value. This is because our Match funded advances have no stated maturity, generally are realized within a relatively short period of time and do not bear interest. The fair value measurements for Match funded advances are categorized as Level 3.
Loans Held for Investment
Loans held for investment relate to our GNMA EBO loans. The fair value estimate of these loans was determined by using an internal discounted cash flow model. The fair value measurements for Loans held for investment are categorized as Level 3.
Match Funded Liabilities
Match funded liabilities include various series of term notes, variable funding notes and other fixed rate liabilities. The fair value estimate of the Company’s term notes and other fixed rate liabilities was determined by using broker quotes. We concluded that no adjustments were required to the quoted prices. The level of trading, both in number of trades and amount of term notes traded, is at a level that the Company believes market quotes to be a reasonable representation of the current fair market value of the term notes. All other Match funded liabilities are short term in nature and the carrying value generally approximates the fair value. The fair value measurements for Match funded liabilities are categorized as Level 3.
Other Borrowings
Other borrowings include a senior secured term loan facility and Mortgage Loan Facility. The fair value estimate of the senior secured term loan facility was determined by using broker quotes. We concluded that no adjustments were required to the quoted price. Trading is at a level that the Company believes market quotes to be a reasonable representation of the current fair market value of this facility. The Mortgage Loan Facility is short term in nature and the carrying value generally approximates the fair value. The fair value measurements for both facilities are categorized as Level 3.

Match_Funded_Advances

Match Funded Advances	3 Months Ended
	Mar. 31, 2014
Transfers and Servicing [Abstract]	'
Match Funded Advances	'
	MATCH FUNDED ADVANCES
	Match funded advances on residential loans we service for others are comprised of the following at the dates indicated:
		March 31,		December 31,
		2014		2013
	Principal and interest advances	$	2,724,333	$	2,632,092
	Taxes and insurance advances	2,665,270		2,723,390
	Corporate advances	953,794		1,032,299
		$	6,343,397	$	6,387,781

Other_Assets

Other Assets	3 Months Ended
	Mar. 31, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Other Assets	'
	5. OTHER ASSETS
	Other assets consisted of the following at the dates indicated:
		March 31,		December 31,
		2014		2013
	Debt service accounts (1)	$	106,987	$	103,910
	Debt issuance costs (2)	22,669		21,165
	Accrued interest income (3)	2,255		—
	Interest-earning collateral deposits (4)	1,075		1,075
	Derivative financial instruments (5)	3,523		3,835
	Advance financing receivables (6)	55,702		—
	Other	558		168
		$	192,769	$	130,153
	-1	Under our advance funding facilities, we are contractually required to remit collections on Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $3,526 which will be used to pay down a portion of the Mortgage Loan Facility balance on the first funding date following quarter end.
	-2	Costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
	-3	Represents accrued interest income on our GNMA EBO loans and interest earned on our financing of GNMA EBO advances. The GNMA EBO loans remain on accrual status as collection is reasonably assured. GNMA EBO advance financing interest income is settled on a monthly basis.
	-4	Represents cash collateral held by our counterparty as part of our interest rate swap agreements.
	-5	See Notes 3 and 9 for more information regarding our use of derivatives.
	-6	We provided financing to Ocwen for GNMA EBO advances as part of the GNMA EBO Transaction. We accounted for this as a financing transaction and receive interest income at a rate of 1- Month LIBOR plus 450 bps.

Match_Funded_Liabilities

Match Funded Liabilities	3 Months Ended
	Mar. 31, 2014
Text Block [Abstract]	'
Match Funded Liabilities	'
	MATCH FUNDED LIABILITIES
	Match funded liabilities are comprised of the following at the dates indicated:
								Balance Outstanding
	Borrowing Type(1)		Interest Rate (2)	Maturity (3)	Amortization Date (3)	Unused Borrowing Capacity (4)		March 31, 2014 (5)		December 31, 2013
	Series 2012 T2 Term Notes		199 – 494 bps	Oct. 2045	Oct. 2015	$	—	$	450,000	$	450,000
	Series 2013 T1 Term Notes		90 – 249 bps	Jan. 2044	Jan. 2014	—		—		650,000
	Series 2013 T1 Term Notes		150 – 323 bps	Jan. 2046	Jan. 2016	—		350,000		350,000
	Series 2013 T1 Term Notes		229 – 446 bps	Jan. 2048	Jan. 2018	—		150,000		150,000
	Series 2013 T2 Term Notes		115 – 239 bps	May-44	May-15	—		375,000		375,000
	Series 2013 T3 Term Notes		179 – 313 bps	May-46	May-17	—		475,000		475,000
	Series 2013 T4 Term Notes		118 – 232 bps	Aug. 2044	Aug. 2014	—		200,000		200,000
	Series 2013 T5 Term Notes		198 – 331 bps	Aug. 2046	Aug. 2016	—		200,000		200,000
	Series 2013 T6 Term Notes		129 – 223 bps	Sep. 2044	Sep. 2014	—		350,000		350,000
	Series 2013 T7 Term Notes		198 – 302 bps	Nov. 2046	Nov. 2016	—		300,000		300,000
	Series 2014 T1 Term Notes		124 – 229 bps	Jan. 2045	Jan. 2015	—		600,000		—
	Series 2014 T2 Term Notes		222 – 311 bps	Jan. 2047	Jan. 2017	—		200,000		—
	Series 2012 VF 1 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2012 VF 2 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2012 VF 3 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2013 VF 1 Notes (6)		1-Month LIBOR + 150 - 245 bps	Feb. 2045	Feb. 2015	51,748		498,252		514,972
	Class A Term Money Market Fund Note (7)		1-Month LIBOR + 20 bps	Sep. 2014	Jan. 2014	—		176,667		265,000
	Class A Draw Money Market Fund Note (7)		1-Month LIBOR + 110 bps	Sep. 2044	Sep. 2014	—		88,333		—
	Class B Term Money Market Fund Note		275 bps	Sep. 2044	Sep. 2014	—		28,500		28,500
						$	818,320	$	5,775,180	$	5,715,622
	-1	Each term note and variable funding note issuance has four classes, an A, B, C, and D class.
	-2	The weighted average interest rate at March 31, 2014 was 1.68%. We pay interest monthly.
	-3	The amortization date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
	-4	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity which varies by facility.
	-5	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes.
	-6	These Variable Funding Notes were amended on February 14, 2014, to extend the amortization and maturity dates by a year and to reduce the interest rate spreads compared to December 31, 2013. Variable Funding Note balances fluctuate based on Match funded advance activity and our ability to issue fixed rate term notes.
	-7	The Class A Term Money Market Fund Note and Class A Draw Money Market Fund Note have a combined maximum borrowing capacity of $265,000. By design, the Class A Term Money Market Fund Note balance is reduced at scheduled times and there is an equally offsetting increase to the Class A Draw Money Market Fund Note. The combined balance of these notes was equal to $265,000 at March 31, 2014 and December 31, 2013. The amortization date for the Class A Term Money Market Fund Note represents the commencement date for scheduled repayments.
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of March 31, 2014
	2014	$	2,176,928
	2015	1,923,252
	2016	850,000
	2017	675,000
	2018 and thereafter	150,000
	Total	$	5,775,180
	-1	The expected maturity date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.

Other_Borrowings

Other Borrowings	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Other Borrowings	'
	OTHER BORROWINGS
	Other borrowings consisted of the following at the dates indicated:
		March 31, 2014		December 31, 2013
	Senior secured term loan facility (1)	$	342,697	$	343,386
	Mortgage Loan Facility (2)	472,734		—
		$	815,431	$	343,386
	-1	On June 27, 2013, we entered into a $350,000 senior secured term loan facility which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of March 31, 2014, the interest rate on our senior secured term loan facility was 4.50%.
	-2	On March 3, 2014, we entered into a Mortgage Loan Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1- Month LIBOR plus 305 bps. The Mortgage Loan Facility has maximum borrowing capacity of $600,000, $127,266 of which was unused as of March 31, 2014.
	The weighted average interest rate for our Other borrowings was 3.75% as of March 31, 2014.
	Analysis of Other Borrowing by Expected Repayment Date (1):
	Year of Expected Payment Date	As of March 31, 2014
	2014	$	2,625
	2015	476,234
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total	$	820,109
	-1	The Mortgage Loan Facility expected payment date is based on the current outstanding balance and maturity date of the facility.

Ordinary_Shares

Ordinary Shares	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Ordinary Shares	'
	ORDINARY SHARES
	Increases in the number of ordinary shares issued during the three months ended March 31, 2014 and March 31, 2013 are represented in the table below:
		2014	2013
	Ordinary shares issued - beginning balance	71,016,771	55,884,718
	Issuance of new ordinary shares	—	970,578
	Ordinary shares issued – ending balance	71,016,771	56,855,296
	On January 22, 2013, the underwriters exercised a portion of their over-allotment option from our December 24, 2012 offering of ordinary shares in the amount of 970,578 ordinary shares. We received net proceeds of $17,633 from the over-allotment exercise.

Derivative_Financial_Instrumen

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	DERIVATIVE FINANCIAL INSTRUMENTS
	We are party to interest rate swap agreements that we recognize on our Interim Condensed Consolidated Balance Sheet at fair value within Other assets and Other liabilities. On the date we entered into the interest rate swap agreements, we designated and documented them as hedges of the variable cash flows payable for floating rate interest expense on our borrowings (cash flow hedge). To qualify for hedge accounting, a derivative must be highly effective at reducing the risk associated with the hedged exposure. In addition, the documentation must include the risk management objective and strategy. On a quarterly basis we assess and document the derivatives’ effectiveness and expected effectiveness in offsetting the changes in the fair value or the cash flows of the hedged items. To assess effectiveness, we use statistical methods, such as regression analysis, as well as nonstatistical methods including dollar-offset analysis. For a cash flow hedge, to the extent that it is effective, we record changes in the estimated fair value of the derivative in other comprehensive income. We subsequently reclassify these changes in estimated fair value to net income in the same period that the hedged transaction affects earnings and in the same financial statement category as the hedged item.
	If a derivative instrument in a cash flow hedge is terminated or the hedge designation is removed, we reclassify related amounts in AOCI into earnings in the same period during which the cash flows that were hedged affect earnings. In a period where we determine that it is probable that a hedged forecasted transaction will not occur, such as variable-rate interest payments on debt that has been repaid in advance, any related amounts in AOCI are reclassified into earnings in that period.
	Because our current derivative agreements are not exchange-traded, we are exposed to credit loss in the event of nonperformance by the counterparty to the agreement. We control this risk through counterparty credit monitoring procedures including financial analysis, dollar limits and other monitoring procedures. The notional amounts of our contracts do not represent our exposure to credit loss. See Note 3 for additional information regarding our use of derivatives.
	Interest Rate Management
	We executed a hedging strategy designed to mitigate the impact of changes in variable interest rates on the excess of interest rate sensitive liabilities over interest rate sensitive assets. We entered into interest rate swaps to hedge against the effects of a change in 1-Month LIBOR.
	The following tables provide information about our interest rate swaps at March 31, 2014 and December 31, 2013, respectively:
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(2),(3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12	Sep-12		Aug-17	0.5188	%	1-Month LIBOR	Other assets	$	141,049	$	1,079
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-16		Dec-17	1.3975	%	1-Month LIBOR	Other assets	338,009		2,444
	Total asset derivatives designated as hedges as of March 31, 2014										$	479,058	$	3,523
	Total asset derivatives as of March 31, 2014										$	479,058	$	3,523
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(2),(3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12	Mar-12		Mar-16	0.6325	%	1-Month LIBOR	Other liabilities	$	96,927	$	343
	Hedge the effects of changes in 1-Month LIBOR		May-12	May-12		May-16	0.607	%	1-Month LIBOR	Other liabilities	25,225		15
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-14		Jul-14	0.3375	%	1-Month LIBOR	Other liabilities	207,048		86
	Total liability derivatives designated as hedges as of March 31, 2014										$	329,200	$	444
	Total liability derivatives as of March 31, 2014										$	329,200	$	444
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12	Sep-12		Aug-17	0.5188	%	1-Month LIBOR	Other assets	$	177,056	$	1,084
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-16		Dec-17	1.3975	%	1-Month LIBOR	Other assets	338,009		2,751
	Total asset derivatives designated as hedges as of December 31, 2013										$	515,065	$	3,835
	Total asset derivatives as of December 31, 2013										$	515,065	$	3,835
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12	Mar-12		Mar-16	0.6325	%	1-Month LIBOR	Other liabilities	$	102,522	$	364
	Hedge the effects of changes in 1-Month LIBOR		May-12	May-12		May-16	0.607	%	1-Month LIBOR	Other liabilities	28,565		25
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-14		Jul-14	0.3375	%	1-Month LIBOR	Other liabilities	307,043		140
	Total liability derivatives designated as hedges as of December 31, 2013										$	438,130	$	529
	Total liability derivatives as of December 31, 2013										$	438,130	$	529
	-1	The effective date of the swap is the date from which monthly net settlements begin to be computed.
	-2	Projected net settlements for the next twelve months total approximately $1,033 of payments to the counterparty.
	-3	There was an unrealized pre-tax loss of $227 related to our interest rate swaps included in AOCI for the three months ended March 31, 2014, and an unrealized pre-tax gain of $13 related to our interest rate swaps included in AOCI for the three months ended March 31, 2013. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
	The following table summarizes our use of derivatives during the three months ended March 31:
		2014			2013
	Notional balance at beginning of period	$	953,195		$	414,631
	Additions	—			645,052
	Maturities	—			—
	Terminations	—			—
	Amortization	144,937			33,631
	Notional balance at end of period	$	808,258		$	1,026,052
	We recognize the right to reclaim cash collateral or the obligation to return cash collateral as part of our hedge agreements. At March 31, 2014, we have the right to reclaim cash collateral of $1,075 and are obligated to return cash collateral of $3,510 as part of our hedge agreements. At December 31, 2013, we had the right to reclaim cash collateral of $1,075 and are obligated to return cash collateral of $3,500 as part of our hedge agreements.

Interest_Income

Interest Income	3 Months Ended
	Mar. 31, 2014
Other Income and Expenses [Abstract]	'
Interest Income	'
	INTEREST INCOME
	Interest Income – Notes Receivable – Rights to MSRs
	Our primary source of revenue is the fees we are entitled to receive in connection with the servicing of mortgage loans. We account for these fees as interest income.
	The following table shows how we calculated Interest income - notes receivable – Rights to MSRs for the three months ended March 31:
		Three Months
		2014			2013
	Servicing fees collected	$	189,157		$	102,258
	Subservicing fee payable to Ocwen	(90,644		)	(47,052		)
	Net servicing fees retained by HLSS	98,513			55,206
	Reductions in Notes receivable – Rights to MSRs	—			(7,339		)
	Increase in fair value of Notes receivable – Rights to MSRs	4,025			—
		$	102,538		$	47,867
	Interest Income – Other
	Additional sources of revenue for us are the interest we earn on our GNMA EBO loans, financing of GNMA EBO advances, operating bank accounts and the custodial account balances related to the mortgage loans serviced which are not included in our Interim Condensed Consolidated Balance Sheets. The following table shows our Interest income – other in more detail for the three months ended March 31:
		Three Months
		2014			2013
	Loan interest (1)	$	1,784		$	—
	Advance financing interest (2)	202			—
	Bank account interest	975			102
		$	2,961		$	102
	-1	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO loans using the interest method of accounting.
	-2	Represents interest earned on advance financing we provided to Ocwen in connection with their role as a servicer of agency loans.

Interest_Expense

Interest Expense	3 Months Ended
	Mar. 31, 2014
Interest Expense [Abstract]	'
Interest Expense	'
	INTEREST EXPENSE
	The following table presents the components of Interest expense for the three months ended March 31:
		Three Months
		2014		2013
	Match funded liabilities	$	26,830	$	14,781
	Other borrowings	5,323		—
	Amortization of debt issuance costs	4,962		3,106
	Interest rate swaps	396		355
		$	37,511	$	18,242

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	Income taxes were provided for based upon the tax laws and rates in countries in which we conduct operations and earn related income. Our effective tax rate for the three months ended March 31, 2014 and 2013 was 0.0% and 0.1%. We are a Cayman Islands exempted company, and the Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation.
	The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities. As of March 31, 2014, the Company did not have any unrecognized tax benefits related to the current period or any previous period. We recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We did not accrue interest or penalties associated with any unrecognized tax benefits, nor was any interest expense or penalty recognized during the period or in previous periods.

Business_Segment_Reporting

Business Segment Reporting	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Business Segment Reporting	'
	BUSINESS SEGMENT REPORTING
	Our business strategy focuses on acquiring residential mortgage assets consisting of mortgage servicing rights, rights to fees and mortgage loans. As of March 31, 2014, we operate a single reportable business segment that holds residential mortgage assets.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	RELATED PARTY TRANSACTIONS
	We entered into various agreements with Ocwen and Altisource Portfolio Solutions, S.A. (“Altisource”) in connection with our Initial Public Offering on March 5, 2012. William C. Erbey, our founder and the Chairman of our Board of Directors, is also the Chairman of the Board of Directors of Ocwen and Altisource.
	As the named servicer, Ocwen remains obligated to perform as servicer under the related PSAs, and we are required to pay Ocwen a monthly fee for the servicing activities it performs. We are also required to purchase any servicing advances that Ocwen is required to make pursuant to such PSAs.
	In addition to the acquisition of residential mortgage assets described in Note 2, the following table summarizes our transactions with Ocwen for the three months ended March 31:
		Three Months
		2014			2013
	Servicing fees collected	$	189,157		$	102,258
	Subservicing fee payable to Ocwen	(90,644		)	(47,052		)
	Net servicing fees retained by HLSS	98,513			55,206
	Reductions in Notes receivable – Rights to MSRs	—			(7,339		)
	Increase in fair value of Notes receivable – Rights to MSRs	4,025			—
		102,538			47,867
	Servicing advances purchased from Ocwen in the ordinary course of business	$	3,503,375		$	695,105
	At March 31, 2014, Ocwen owed us $8,087 for servicing fees collected but not remitted to us, and we owed Ocwen $3,738 for the subservicing fee earned by Ocwen in March 2014. Ocwen owed us $2,053 for accrued GNMA EBO loan interest income and $202 for accrued advance financing interest income as of March 31, 2014. During the three months ended March 31, 2014 and 2013, we earned interest income of $1,986 and $0 as a result of the GNMA EBO Transaction with Ocwen. Lastly, our Notes receivable – Rights to MSRs resulted from transactions with Ocwen.
	Ocwen Professional Services Agreement
	We have a professional services agreement with Ocwen (“Professional Services Agreement”) that requires us to provide certain services to Ocwen and for Ocwen to provide certain services with pricing terms intended to reflect market rates. Services provided by us under this agreement include valuation and analysis of mortgage servicing rights, capital markets activities, advance financing management, treasury management, legal services and other similar services. Services provided by Ocwen under this agreement include business strategy, legal, tax, licensing and regulatory compliance support services, risk management services and other similar services. The services provided by the parties under this agreement are on an as-needed basis, and the fees represent actual costs incurred plus an additional markup of 15%.
	At March 31, 2014, Ocwen owed us $1,284 for professional services provided pursuant to the Professional Services Agreement. During the three months ended March 31, 2014 and 2013 we earned fees of $628 and $407, for services provided to Ocwen pursuant to the Professional Services Agreement. Additionally, during the three months ended March 31, 2014 and 2013 we incurred fees of $154 and $30 for services received from Ocwen pursuant to the Professional Services Agreement.
	Altisource Administrative Services Agreement
	We have an administrative services agreement with Altisource (“Altisource Administrative Services Agreement”) that requires Altisource to provide certain administrative services to us with pricing terms intended to reflect market rates. Services provided to us under this agreement include human resources administration (benefit plan design, recruiting, hiring and training and compliance support), legal and regulatory compliance support services, general business consulting, corporate services (facilities management, security and travel services), finance and accounting support services (financial analysis, financial reporting and tax services), risk management services, vendor management and other related services. The services Altisource provides to us under this agreement are on an as-needed basis, and the fees we pay Altisource are based on the actual costs incurred by them plus an additional markup of 15%. During the three months ended March 31, 2014 and March 31, 2013, we incurred fees of $218 and $196 for services provided to us pursuant to the Altisource Administrative Services Agreement.
	Receivables from and Payables to Related Parties
	The following table summarizes amounts receivable from and payable to related parties at the dates indicated:
		March 31, 2014			December 31, 2013
	Servicing fees collected (1)	$	8,087		$	8,482
	Professional services (2)	1,284			655
	Advance collections (3)	56,655			60,239
	Other	1,573			673
	Receivables from Ocwen	$	67,599		$	70,049
	Subservicing fees payable (4)	$	3,738		$	8,114
	Professional services (2)	508			354
	Other	3,621			2,181
	Payables to Ocwen	$	7,867		$	10,649
	Payables to Altisource	$	18		$	83
	-1	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at March 31, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 10.
	-2	The respective amounts are for professional services provided that were receivable as of the dates indicated.
	-3	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
	-4	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	We may be party to various claims, legal actions and complaints arising in the ordinary course of business. We monitor our legal matters, including advice from external legal counsel, and periodically perform assessments of these matters for potential loss accrual and disclosure. There are currently no probable matters outstanding that, in the opinion of management, will have a material effect on our Interim Condensed Consolidated Balance Sheets, Statements of Operations and Statements of Cash Flows. There are also currently no reasonably possible matters outstanding that, in the opinion of management, will have a material effect on our Interim Condensed Consolidated Balance Sheets, Statements of Operations and Statements of Cash Flows.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	Subsequent to our balance sheet date of March 31, 2014:
	•	On April 10, 2014, we paid cash dividends of $10,653 or $0.15 per ordinary share; and
	•	On April 17, 2014, we declared a monthly dividend of $0.16 per ordinary share with respect to April, May and June 2014.

Restatement_Notes

Restatement (Notes)	3 Months Ended
	Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]	'
Restatement	'
	RESTATEMENT
	Subsequent to the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, (the “Original Form 10-K”), with the SEC on February 6, 2014 and the filing of the Original Form 10-Q for the three months ended March 31, 2014, we determined that the Notes Receivable - Rights to MSRs and related interest income were materially misstated due to the fact that we did not adjust the Notes Receivable - Rights to MSRs to the best estimate of fair value and did not include the effect of such fair value adjustments in the application of the interest method in accounting for the Notes receivable - Rights to MSRs. As a result, the following financial statement amounts have been restated from amounts previously reported.
	The following table summarizes the effects of the restatement on the consolidated balance sheet as of March 31, 2014 and December 31, 2013 (as restated on the Form 10-K/A filed on August 18, 2014).
		March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable - Rights to MSRs	$	634,399		$	3,395		$	637,794
	All other assets	7,233,353			—			7,233,353
	Total assets	$	7,867,752		$	3,395		$	7,871,147
	Total liabilities	$	6,622,447		$	—		$	6,622,447
	Retained earnings	32,520			3,395			35,915
	All other equity	1,212,785			—			1,212,785
	Total equity	1,245,305			3,395			1,248,700
	Total liabilities and equity	$	7,867,752		$	3,395		$	7,871,147
		December 31, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable - Rights to MSRs	$	651,060		$	(17,291	)	$	633,769
	All other assets	6,676,903			—			6,676,903
	Total assets	$	7,327,963		$	(17,291	)	$	7,310,672
	Total liabilities	$	6,094,225		$	—		$	6,094,225
	Retained earnings	20,804			(17,291		)	3,513
	All other equity	1,212,934			—			1,212,934
	Total equity	1,233,738			(17,291		)	1,216,447
	Total liabilities and equity	$	7,327,963		$	(17,291	)	$	7,310,672
	The following table summarizes the effects of the restatement on the consolidated statements of operations for the three months ended March 31, 2014 and 2013.
		Three months ended March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable - Rights to MSRs	$	81,852		$	20,686		$	102,538
	Interest income – other	2,961			—			2,961
	Total interest income	84,813			20,686			105,499
	Related party revenue	628			—			628
	Total revenue	85,441			20,686			106,127
	Operating expenses	4,256			—			4,256
	Income from operations	81,185			20,686			101,871
	Other expense
	Interest expense	37,511			—			37,511
	Total other expense	37,511			—			37,511
	Income before income taxes	$	43,674		$	20,686		$	64,360
	Income tax expense	—			—			—
	Net income	$	43,674		$	20,686		$	64,360
	Earnings per share
	Earnings per share	$	0.61		$	0.3		$	0.91
	Diluted earnings per share	$	0.61		$	0.3		$	0.91
		Three months ended March 31, 2013 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	44,570		$	3,297		$	47,867
	Interest income – other	102			—			102
	Total interest income	44,672			3,297			47,969
	Related party revenue	407			—			407
	Total revenue	45,079			3,297			48,376
	Operating expenses	2,037			—			2,037
	Income from operations	43,042			3,297			46,339
	Other expense
	Interest expense	18,242			—			18,242
	Total other expense	18,242			—			18,242
	Income before income taxes	24,800			3,297			28,097
	Income tax expense	12			—			12
	Net income	$	24,788		$	3,297		$	28,085
	Earnings per share
	Earnings per share	$	0.44		$	0.06		$	0.5
	Diluted earnings per share	$	0.44		$	0.06		$	0.5
	The following table summarizes the effects of the restatement on the consolidated statements of comprehensive income for the three months ended March 31, 2014 and 2013.
		Three months ended March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	43,674		$	20,686		$	64,360
Total other comprehensive loss, before tax	(227		)	—			(227		)
Tax benefit on other comprehensive loss	78			—			78
Total other comprehensive loss, net of tax	(149		)	—			(149		)
Total comprehensive income	$	43,525		$	20,686		$	64,211
	Three months ended March 31, 2013 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	24,788		$	3,297		$	28,085
Total other comprehensive income, before tax	13			—			13
Tax expense on other comprehensive income	—			—			—
Total other comprehensive income, net of tax	13			—			13
Total comprehensive income	$	24,801		$	3,297		$	28,098
The following table summarizes the effects of the restatement on the consolidated statements of cash flows for the three months ended March 31, 2014 and 2013.
	March 31, 2014 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	43,674		$	20,686		$	64,360
Increase in fair value of Notes receivable – Rights to MSRs	—			(4,025		)	(4,025		)
All other operating cash flows	43,432			—			43,432
Net cash provided by operating activities	87,106			16,661			103,767
Reduction in Notes receivable – Rights to MSRs	16,661			(16,661		)	—
All other investing cash flows	(608,794		)	—			(608,794		)
Net cash used in investing activities	(592,133		)	(16,661		)	(608,794		)
Net cash provided by financing activities	493,051			—			493,051
Net decrease in cash and cash equivalents	(11,976		)	—			(11,976		)
Cash and cash equivalents at beginning of period	87,896			—			87,896
Cash and cash equivalents at end of period	$	75,920		$	—		$	75,920
	March 31, 2013 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	24,788		$	3,297		$	28,085
All other operating cash flows	342,306			—			342,306
Net cash provided by operating activities	367,094			3,297			370,391
Reduction in Notes receivable – Rights to MSRs	10,636			(3,297		)	7,339
All other investing cash flows	(814,319		)	—			(814,319		)
Net cash used in investing activities	(803,683		)	(3,297		)	(806,980		)
Net cash provided by financing activities	421,698			—			421,698
Net decrease in cash and cash equivalents	(14,891		)	—			(14,891		)
Cash and cash equivalents at beginning of period	76,048			—			76,048
Cash and cash equivalents at end of period	$	61,157		$	—		$	61,157

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization	'
	Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries (collectively referred to throughout as “HLSS”, “us”, “our”, “we” or the “Company”) focus on acquiring residential mortgage assets.
Basis of Presentation and Use of Estimates	'
	We prepared the accompanying unaudited Interim Condensed Consolidated Financial Statements in conformity with the instructions of the Securities and Exchange Commission (“SEC”) to Form 10-Q for interim financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. Material estimates that are particularly significant relate to our fair value measurements of Notes receivable – Rights to MSRs.
Principles of Consolidation	'
	Our financial statements include the accounts of Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries, as well as three variable interest entities (“VIE”) of which we are the primary beneficiary. We eliminate intercompany accounts and transactions in consolidation.
	We evaluate each special purpose entity (“SPE”) for classification as a VIE. When a SPE meets the definition of a VIE and we determine that HLSS is the primary beneficiary, we include the SPE in our Interim Condensed Consolidated Financial Statements.
	Our Match funded advances are in two SPEs along with related Match funded liabilities. We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Match funded advances on loans serviced for others result from our transfers of residential loan servicing advances to SPEs in exchange for cash. The SPEs issue debt supported by collections on the transferred advances. We made these transfers under the terms of our advance facility agreements. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred advances on our Interim Condensed Consolidated Balance Sheet as Match funded advances and the related liabilities as Match funded liabilities. We use collections on the Match funded advances pledged to the SPEs to repay principal and to pay interest and the expenses of the entity. Holders of the debt issued by this entity can look only to the assets of the entity itself for satisfaction of the debt and have no recourse against HLSS.
	On March 3, 2014, we acquired Government National Mortgage Association (“GNMA”) loans from Ocwen with an unpaid principal balance (“UPB”) of $549,411. Ocwen initially acquired these loans through the GNMA early buy-out (“EBO”) program which allows servicers of GNMA insured loans to buy delinquent loans from the applicable loan securitization pools. We account for these GNMA EBO loans as “Loans held for investment,” as described more fully later in this footnote. We also financed the GNMA EBO advances related to the GNMA EBO loans, and we account for this arrangement as a financing transaction because Ocwen retained title and all other rights and rewards associated with the GNMA EBO advances. Collectively, the purchase of GNMA EBO loans and financing of the related advances are referred to as the “GNMA EBO Transaction.” Our GNMA EBO loans are in a SPE with a related financing facility ("Mortgage Loan Facility"). The accounts of this SPE are included in our Interim Condensed Consolidated Financial Statements. These transfers to the SPE do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred GNMA EBO loans on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the GNMA EBO loans pledged to the SPE to repay principal and to pay interest and the expenses of the entity. The holders of the debt issued by this SPE can look beyond the assets of the SPE for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that since our GNMA EBO loans are insured by the Federal Housing Administration (“FHA”), the cash flows of this SPE will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPE.
Recent Accounting Pronouncements	'
	Accounting Standards Update (“ASU”) ASU 2013-11. This ASU provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit exists. Previously, there was diversity in practice, and this ASU is expected to eliminate that diversity in practice. The amendments in this update are effective for fiscal years, and interim periods within those years ended beginning after December 15, 2013. Our adoption of this standard effective January 1, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-06. This ASU provides technical corrections and improvements to Accounting Standards Codification glossary terms. Our adoption of this standard, effective March 14, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	Certain disclosures included in the Company’s Annual Report are not required to be included on an interim basis in the Company’s Quarterly Reports on Forms 10-Q. The Company has condensed or omitted these disclosures. Therefore, this Form 10-Q/A should be read in conjunction with the Company’s amended Annual Report on Form 10-K filed with the SEC on August 18, 2014 ("the Form 10-K/A").

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Summary of Assets and Liabilities of SPEs	'
	The following tables summarize the assets and liabilities of our consolidated SPEs, at the dates indicated:
	At March 31, 2014		Match Funded Advance SPEs		Mortgage Loans SPE		Total
	Match funded advances		$	6,343,397	$	—	$	6,343,397
	Loans held for investment		—		552,644		552,644
	Related party receivables (1)		56,655		—		56,655
	Other assets (2)		120,980		61,662		182,642
	Total assets		$	6,521,032	$	614,306	$	7,135,338
	Match funded liabilities		$	5,775,180	$	—	$	5,775,180
	Other borrowings(3)		—		472,734		472,734
	Other liabilities		4,525		1,220		5,745
	Total liabilities		$	5,779,705	$	473,954	$	6,253,659
	At December 31, 2013		Match Funded Advance SPEs		Mortgage Loans SPE		Total
	Match funded advances		$	6,387,781	$	—	$	6,387,781
	Loans held for investment		—		—		—
	Related party receivables (1)		60,239		—		60,239
	Other assets (2)		119,902		—		119,902
	Total assets		$	6,567,922	$	—	$	6,567,922
	Match funded liabilities		$	5,715,622	$	—	$	5,715,622
	Other borrowings(3)		—		—		—
	Other liabilities		4,673		—		4,673
	Total liabilities		$	5,720,295	$	—	$	5,720,295
	-1	Related party receivables principally includes Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 14 for more information about our Related party receivables.
	-2	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of the GNMA EBO Transaction. See Note 5 for more information about our Other assets.
	-3	Other borrowings include the carrying value of our Mortgage Loan Facility.

Asset_Acquisitions_Tables

Asset Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2014
Business Combinations [Abstract]	'
Summary of Purchase Price of Assets and Liabilities	'
	The following table summarizes the transaction and reconciles the cash used to acquire the GNMA EBO loans:
	GNMA EBO loans purchase price(1)	$	556,618
	Sources:
	Cash on-hand	$	83,884
	SPE financing	$	472,734
	-1	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.
	The following table summarizes the purchase price of the assets we acquired from Ocwen during the three months ended March 31, 2013 and reconciles the cash used to acquire such assets:
	Notes receivable – Rights to MSRs	$	100,707
	Match funded advances (1)	$	703,206
	Purchase price, as adjusted	$	803,913
	Post-closing adjustments	$	10,406
	Total cash used	$	814,319
	Sources:
	Cash on-hand	$	153,142
	Match funded liabilities	$	661,177
	-1	The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of residential mortgage assets” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value and Change in Fair value of Assets and Liabilities on Recurring Basis	'
	The following tables present reconciliations of the fair value and changes in fair value of our Level 3 assets and liabilities which we measure at fair value on a recurring basis:
	At March 31, 2014:		Fair value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	637,794			$	—			$	—			$	637,794
	Derivative financial instruments		3,523				—				—				3,523
	Total assets		$	641,317			$	—			$	—			$	641,317
	Liabilities:
	Derivative financial instruments		$	444			$	—			$	—			$	444
	Total liabilities		$	444			$	—			$	—			$	444
	At December 31, 2013:		Fair value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	633,769			$	—			$	—			$	633,769
	Derivative financial instruments		3,835				—				—				3,835
	Total assets		$	637,604			$	—			$	—			$	637,604
	Liabilities:
	Derivative financial instruments		$	529			$	—			$	—			$	529
	Total liabilities		$	529			$	—			$	—			$	529
Reconciliation of Changes in Fair Value	'
			2014								2013
	For the three months ended March 31,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	633,769			$	3,306			$	296,451			$	(1,076	)
	Purchases and reductions:
	Purchases		—				—				100,707				—
	Reductions		—				—				(7,339		)		—
			$	—			$	—			$	93,368			$	—
	Changes in fair value :
	Included in net income (1)		4,025				—				—				—
	Included in other comprehensive income (2)		—				(227		)		—				13
			4,025				(227		)		—				13
	Transfers in or out of Level 3		—				—				—				—
	Ending balance		$	637,794			$	3,079			$	389,819			$	(1,063	)
	-1	Changes in fair value of the Notes receivable – Rights to MSRs are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 10 for additional information regarding our Interest income.
	-2	These pre-tax gains (losses) are attributable to derivatives still held at March 31, 2014 and March 31, 2013, respectively.
Effect on Fair Value of Note Receivable - Rights to MSRs	'
	The following table shows the effect on the fair value of the Notes receivable – Rights to MSRs assuming adverse changes to certain key assumptions used in valuing these assets at March 31, 2014 and December 31, 2013:
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At March 31, 2014:
	Notes receivable – Rights to MSRs	$	(12,936	)		$	(21,693	)		$	(71,773	)
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At December 31, 2013:
	Notes receivable – Rights to MSRs	$	(12,988	)		$	(22,537	)		$	(72,560	)
Quantitative Information on Significant Observable Inputs Used for Valuing Note Receivable - Rights to MSRs	'
	The following table provides additional quantitative information on our significant inputs used for valuing our Notes receivable – Rights to MSRs as of March 31, 2014 and December 31, 2013, respectively:
	At March 31, 2014:
	Asset	Unobservable Input		Low			High			Weighted Average
	Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		19	%
		Prepayment Speeds		12	%		28	%		18	%
		Delinquency Rates		15	%		35	%		24	%
	At December 31, 2013:
	Asset	Unobservable Input		Low			High			Weighted Average
	Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		20	%
		Prepayment Speeds		12	%		28	%		19	%
		Delinquency Rates		15	%		35	%		25	%
Carrying Values and Fair Value Estimates of Financial Instruments Not Carried at Fair Value	'
	Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value at the dates indicated:
		March 31, 2014				March 31, 2014				December 31, 2013				December 31, 2013
		Carrying Value				Fair Value				Carrying Value				Fair Value
	Financial assets:
	Match funded advances	$	6,343,397			$	6,343,397			$	6,387,781			$	6,387,781
	Loans held for investment	552,644				552,644				—				—
	Total financial assets	$	6,896,041			$	6,896,041			$	6,387,781			$	6,387,781
	Financial liabilities:
	Match funded liabilities	$	5,775,180			$	5,770,270			$	5,715,622			$	5,700,934
	Other borrowings	815,431				817,144				343,386				346,391
	Total financial liabilities	$	6,590,611			$	6,587,414			$	6,059,008			$	6,047,325

Match_Funded_Advances_Tables

Match Funded Advances (Tables)	3 Months Ended
	Mar. 31, 2014
Transfers and Servicing [Abstract]	'
Match Funded Advances on Residential Loans	'
	Match funded advances on residential loans we service for others are comprised of the following at the dates indicated:
		March 31,		December 31,
		2014		2013
	Principal and interest advances	$	2,724,333	$	2,632,092
	Taxes and insurance advances	2,665,270		2,723,390
	Corporate advances	953,794		1,032,299
		$	6,343,397	$	6,387,781

Other_Assets_Tables

Other Assets (Tables)	3 Months Ended
	Mar. 31, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Other Assets	'
	Other assets consisted of the following at the dates indicated:
		March 31,		December 31,
		2014		2013
	Debt service accounts (1)	$	106,987	$	103,910
	Debt issuance costs (2)	22,669		21,165
	Accrued interest income (3)	2,255		—
	Interest-earning collateral deposits (4)	1,075		1,075
	Derivative financial instruments (5)	3,523		3,835
	Advance financing receivables (6)	55,702		—
	Other	558		168
		$	192,769	$	130,153
	-1	Under our advance funding facilities, we are contractually required to remit collections on Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $3,526 which will be used to pay down a portion of the Mortgage Loan Facility balance on the first funding date following quarter end.
	-2	Costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
	-3	Represents accrued interest income on our GNMA EBO loans and interest earned on our financing of GNMA EBO advances. The GNMA EBO loans remain on accrual status as collection is reasonably assured. GNMA EBO advance financing interest income is settled on a monthly basis.
	-4	Represents cash collateral held by our counterparty as part of our interest rate swap agreements.
	-5	See Notes 3 and 9 for more information regarding our use of derivatives.
	-6	We provided financing to Ocwen for GNMA EBO advances as part of the GNMA EBO Transaction. We accounted for this as a financing transaction and receive interest income at a rate of 1- Month LIBOR plus 450 bps.

Match_Funded_Liabilities_Table

Match Funded Liabilities (Tables)	3 Months Ended
	Mar. 31, 2014
Text Block [Abstract]	'
Match Funded Liabilities	'
	Match funded liabilities are comprised of the following at the dates indicated:
								Balance Outstanding
	Borrowing Type(1)		Interest Rate (2)	Maturity (3)	Amortization Date (3)	Unused Borrowing Capacity (4)		March 31, 2014 (5)		December 31, 2013
	Series 2012 T2 Term Notes		199 – 494 bps	Oct. 2045	Oct. 2015	$	—	$	450,000	$	450,000
	Series 2013 T1 Term Notes		90 – 249 bps	Jan. 2044	Jan. 2014	—		—		650,000
	Series 2013 T1 Term Notes		150 – 323 bps	Jan. 2046	Jan. 2016	—		350,000		350,000
	Series 2013 T1 Term Notes		229 – 446 bps	Jan. 2048	Jan. 2018	—		150,000		150,000
	Series 2013 T2 Term Notes		115 – 239 bps	May-44	May-15	—		375,000		375,000
	Series 2013 T3 Term Notes		179 – 313 bps	May-46	May-17	—		475,000		475,000
	Series 2013 T4 Term Notes		118 – 232 bps	Aug. 2044	Aug. 2014	—		200,000		200,000
	Series 2013 T5 Term Notes		198 – 331 bps	Aug. 2046	Aug. 2016	—		200,000		200,000
	Series 2013 T6 Term Notes		129 – 223 bps	Sep. 2044	Sep. 2014	—		350,000		350,000
	Series 2013 T7 Term Notes		198 – 302 bps	Nov. 2046	Nov. 2016	—		300,000		300,000
	Series 2014 T1 Term Notes		124 – 229 bps	Jan. 2045	Jan. 2015	—		600,000		—
	Series 2014 T2 Term Notes		222 – 311 bps	Jan. 2047	Jan. 2017	—		200,000		—
	Series 2012 VF 1 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2012 VF 2 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2012 VF 3 Notes		1-Month LIBOR + 110 – 340 bps	Aug. 2044	Aug. 2014	255,524		444,476		469,050
	Series 2013 VF 1 Notes (6)		1-Month LIBOR + 150 - 245 bps	Feb. 2045	Feb. 2015	51,748		498,252		514,972
	Class A Term Money Market Fund Note (7)		1-Month LIBOR + 20 bps	Sep. 2014	Jan. 2014	—		176,667		265,000
	Class A Draw Money Market Fund Note (7)		1-Month LIBOR + 110 bps	Sep. 2044	Sep. 2014	—		88,333		—
	Class B Term Money Market Fund Note		275 bps	Sep. 2044	Sep. 2014	—		28,500		28,500
						$	818,320	$	5,775,180	$	5,715,622
	-1	Each term note and variable funding note issuance has four classes, an A, B, C, and D class.
	-2	The weighted average interest rate at March 31, 2014 was 1.68%. We pay interest monthly.
	-3	The amortization date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
	-4	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity which varies by facility.
	-5	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes.
	-6	These Variable Funding Notes were amended on February 14, 2014, to extend the amortization and maturity dates by a year and to reduce the interest rate spreads compared to December 31, 2013. Variable Funding Note balances fluctuate based on Match funded advance activity and our ability to issue fixed rate term notes.
	-7	The Class A Term Money Market Fund Note and Class A Draw Money Market Fund Note have a combined maximum borrowing capacity of $265,000. By design, the Class A Term Money Market Fund Note balance is reduced at scheduled times and there is an equally offsetting increase to the Class A Draw Money Market Fund Note. The combined balance of these notes was equal to $265,000 at March 31, 2014 and December 31, 2013. The amortization date for the Class A Term Money Market Fund Note represents the commencement date for scheduled repayments.
Analysis of Borrowing by Expected Maturity	'
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of March 31, 2014
	2014	$	2,176,928
	2015	1,923,252
	2016	850,000
	2017	675,000
	2018 and thereafter	150,000
	Total	$	5,775,180
	-1	The expected maturity date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
	Year of Expected Payment Date	As of March 31, 2014
	2014	$	2,625
	2015	476,234
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total	$	820,109
	-1	The Mortgage Loan Facility expected payment date is based on the current outstanding balance and maturity date of the facility.

Other_Borrowings_Tables

Other Borrowings (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Other Borrowings	'
	Other borrowings consisted of the following at the dates indicated:
		March 31, 2014		December 31, 2013
	Senior secured term loan facility (1)	$	342,697	$	343,386
	Mortgage Loan Facility (2)	472,734		—
		$	815,431	$	343,386
	-1	On June 27, 2013, we entered into a $350,000 senior secured term loan facility which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of March 31, 2014, the interest rate on our senior secured term loan facility was 4.50%.
	-2	On March 3, 2014, we entered into a Mortgage Loan Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1- Month LIBOR plus 305 bps. The Mortgage Loan Facility has maximum borrowing capacity of $600,000, $127,266 of which was unused as of March 31, 2014.
Analysis of Borrowing by Maturity	'
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of March 31, 2014
	2014	$	2,176,928
	2015	1,923,252
	2016	850,000
	2017	675,000
	2018 and thereafter	150,000
	Total	$	5,775,180
	-1	The expected maturity date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
	Year of Expected Payment Date	As of March 31, 2014
	2014	$	2,625
	2015	476,234
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total	$	820,109
	-1	The Mortgage Loan Facility expected payment date is based on the current outstanding balance and maturity date of the facility.

Ordinary_Shares_Tables

Ordinary Shares (Tables)	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Increases in Number of Ordinary Shares	'
	Increases in the number of ordinary shares issued during the three months ended March 31, 2014 and March 31, 2013 are represented in the table below:
		2014	2013
	Ordinary shares issued - beginning balance	71,016,771	55,884,718
	Issuance of new ordinary shares	—	970,578
	Ordinary shares issued – ending balance	71,016,771	56,855,296

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Interest Rate Swaps	'
	The following tables provide information about our interest rate swaps at March 31, 2014 and December 31, 2013, respectively:
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(2),(3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12	Sep-12		Aug-17	0.5188	%	1-Month LIBOR	Other assets	$	141,049	$	1,079
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-16		Dec-17	1.3975	%	1-Month LIBOR	Other assets	338,009		2,444
	Total asset derivatives designated as hedges as of March 31, 2014										$	479,058	$	3,523
	Total asset derivatives as of March 31, 2014										$	479,058	$	3,523
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(2),(3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12	Mar-12		Mar-16	0.6325	%	1-Month LIBOR	Other liabilities	$	96,927	$	343
	Hedge the effects of changes in 1-Month LIBOR		May-12	May-12		May-16	0.607	%	1-Month LIBOR	Other liabilities	25,225		15
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-14		Jul-14	0.3375	%	1-Month LIBOR	Other liabilities	207,048		86
	Total liability derivatives designated as hedges as of March 31, 2014										$	329,200	$	444
	Total liability derivatives as of March 31, 2014										$	329,200	$	444
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12	Sep-12		Aug-17	0.5188	%	1-Month LIBOR	Other assets	$	177,056	$	1,084
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-16		Dec-17	1.3975	%	1-Month LIBOR	Other assets	338,009		2,751
	Total asset derivatives designated as hedges as of December 31, 2013										$	515,065	$	3,835
	Total asset derivatives as of December 31, 2013										$	515,065	$	3,835
	Purpose		Date Opened	Effective Date (1)		Maturity	We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges(3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12	Mar-12		Mar-16	0.6325	%	1-Month LIBOR	Other liabilities	$	102,522	$	364
	Hedge the effects of changes in 1-Month LIBOR		May-12	May-12		May-16	0.607	%	1-Month LIBOR	Other liabilities	28,565		25
	Hedge the effects of changes in 1-Month LIBOR		Jan-13	Jan-14		Jul-14	0.3375	%	1-Month LIBOR	Other liabilities	307,043		140
	Total liability derivatives designated as hedges as of December 31, 2013										$	438,130	$	529
	Total liability derivatives as of December 31, 2013										$	438,130	$	529
	-1	The effective date of the swap is the date from which monthly net settlements begin to be computed.
	-2	Projected net settlements for the next twelve months total approximately $1,033 of payments to the counterparty.
	-3	There was an unrealized pre-tax loss of $227 related to our interest rate swaps included in AOCI for the three months ended March 31, 2014, and an unrealized pre-tax gain of $13 related to our interest rate swaps included in AOCI for the three months ended March 31, 2013. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
Summarization of Use of Derivative	'
	The following table summarizes our use of derivatives during the three months ended March 31:
		2014			2013
	Notional balance at beginning of period	$	953,195		$	414,631
	Additions	—			645,052
	Maturities	—			—
	Terminations	—			—
	Amortization	144,937			33,631
	Notional balance at end of period	$	808,258		$	1,026,052

Interest_Income_Tables

Interest Income (Tables)	3 Months Ended
	Mar. 31, 2014
Notes Receivable - Rights to MSRs	'
Calculation of Interest Income on Notes Receivable	'
	The following table shows how we calculated Interest income - notes receivable – Rights to MSRs for the three months ended March 31:
		Three Months
		2014			2013
	Servicing fees collected	$	189,157		$	102,258
	Subservicing fee payable to Ocwen	(90,644		)	(47,052		)
	Net servicing fees retained by HLSS	98,513			55,206
	Reductions in Notes receivable – Rights to MSRs	—			(7,339		)
	Increase in fair value of Notes receivable – Rights to MSRs	4,025			—
		$	102,538		$	47,867
Interest Income - other	'
Calculation of Interest Income on Notes Receivable	'
	The following table shows our Interest income – other in more detail for the three months ended March 31:
		Three Months
		2014			2013
	Loan interest (1)	$	1,784		$	—
	Advance financing interest (2)	202			—
	Bank account interest	975			102
		$	2,961		$	102
	-1	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO loans using the interest method of accounting.
	-2	Represents interest earned on advance financing we provided to Ocwen in connection with their role as a servicer of agency loans.

Interest_Expense_Tables

Interest Expense (Tables)	3 Months Ended
	Mar. 31, 2014
Interest Expense [Abstract]	'
Components of Interest Expense	'
	The following table presents the components of Interest expense for the three months ended March 31:
		Three Months
		2014		2013
	Match funded liabilities	$	26,830	$	14,781
	Other borrowings	5,323		—
	Amortization of debt issuance costs	4,962		3,106
	Interest rate swaps	396		355
		$	37,511	$	18,242

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Transactions with Ocwen under Purchase Agreement	'
	In addition to the acquisition of residential mortgage assets described in Note 2, the following table summarizes our transactions with Ocwen for the three months ended March 31:
		Three Months
		2014			2013
	Servicing fees collected	$	189,157		$	102,258
	Subservicing fee payable to Ocwen	(90,644		)	(47,052		)
	Net servicing fees retained by HLSS	98,513			55,206
	Reductions in Notes receivable – Rights to MSRs	—			(7,339		)
	Increase in fair value of Notes receivable – Rights to MSRs	4,025			—
		102,538			47,867
	Servicing advances purchased from Ocwen in the ordinary course of business	$	3,503,375		$	695,105
Receivable from and Payable to Related Parties	'
	The following table summarizes amounts receivable from and payable to related parties at the dates indicated:
		March 31, 2014			December 31, 2013
	Servicing fees collected (1)	$	8,087		$	8,482
	Professional services (2)	1,284			655
	Advance collections (3)	56,655			60,239
	Other	1,573			673
	Receivables from Ocwen	$	67,599		$	70,049
	Subservicing fees payable (4)	$	3,738		$	8,114
	Professional services (2)	508			354
	Other	3,621			2,181
	Payables to Ocwen	$	7,867		$	10,649
	Payables to Altisource	$	18		$	83
	-1	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at March 31, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 10.
	-2	The respective amounts are for professional services provided that were receivable as of the dates indicated.
	-3	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
	-4	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Restatement_Tables

Restatement (Tables)	3 Months Ended
	Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]	'
Schedule of Error Corrections and Prior Period Adjustments	'
	The following table summarizes the effects of the restatement on the consolidated balance sheet as of March 31, 2014 and December 31, 2013 (as restated on the Form 10-K/A filed on August 18, 2014).
		March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable - Rights to MSRs	$	634,399		$	3,395		$	637,794
	All other assets	7,233,353			—			7,233,353
	Total assets	$	7,867,752		$	3,395		$	7,871,147
	Total liabilities	$	6,622,447		$	—		$	6,622,447
	Retained earnings	32,520			3,395			35,915
	All other equity	1,212,785			—			1,212,785
	Total equity	1,245,305			3,395			1,248,700
	Total liabilities and equity	$	7,867,752		$	3,395		$	7,871,147
		December 31, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable - Rights to MSRs	$	651,060		$	(17,291	)	$	633,769
	All other assets	6,676,903			—			6,676,903
	Total assets	$	7,327,963		$	(17,291	)	$	7,310,672
	Total liabilities	$	6,094,225		$	—		$	6,094,225
	Retained earnings	20,804			(17,291		)	3,513
	All other equity	1,212,934			—			1,212,934
	Total equity	1,233,738			(17,291		)	1,216,447
	Total liabilities and equity	$	7,327,963		$	(17,291	)	$	7,310,672
	The following table summarizes the effects of the restatement on the consolidated statements of operations for the three months ended March 31, 2014 and 2013.
		Three months ended March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable - Rights to MSRs	$	81,852		$	20,686		$	102,538
	Interest income – other	2,961			—			2,961
	Total interest income	84,813			20,686			105,499
	Related party revenue	628			—			628
	Total revenue	85,441			20,686			106,127
	Operating expenses	4,256			—			4,256
	Income from operations	81,185			20,686			101,871
	Other expense
	Interest expense	37,511			—			37,511
	Total other expense	37,511			—			37,511
	Income before income taxes	$	43,674		$	20,686		$	64,360
	Income tax expense	—			—			—
	Net income	$	43,674		$	20,686		$	64,360
	Earnings per share
	Earnings per share	$	0.61		$	0.3		$	0.91
	Diluted earnings per share	$	0.61		$	0.3		$	0.91
		Three months ended March 31, 2013 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	44,570		$	3,297		$	47,867
	Interest income – other	102			—			102
	Total interest income	44,672			3,297			47,969
	Related party revenue	407			—			407
	Total revenue	45,079			3,297			48,376
	Operating expenses	2,037			—			2,037
	Income from operations	43,042			3,297			46,339
	Other expense
	Interest expense	18,242			—			18,242
	Total other expense	18,242			—			18,242
	Income before income taxes	24,800			3,297			28,097
	Income tax expense	12			—			12
	Net income	$	24,788		$	3,297		$	28,085
	Earnings per share
	Earnings per share	$	0.44		$	0.06		$	0.5
	Diluted earnings per share	$	0.44		$	0.06		$	0.5
	The following table summarizes the effects of the restatement on the consolidated statements of comprehensive income for the three months ended March 31, 2014 and 2013.
		Three months ended March 31, 2014 (Unaudited)
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	43,674		$	20,686		$	64,360
	Total other comprehensive loss, before tax	(227		)	—			(227		)
Tax benefit on other comprehensive loss	78			—			78
Total other comprehensive loss, net of tax	(149		)	—			(149		)
Total comprehensive income	$	43,525		$	20,686		$	64,211
	Three months ended March 31, 2013 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	24,788		$	3,297		$	28,085
Total other comprehensive income, before tax	13			—			13
Tax expense on other comprehensive income	—			—			—
Total other comprehensive income, net of tax	13			—			13
Total comprehensive income	$	24,801		$	3,297		$	28,098
The following table summarizes the effects of the restatement on the consolidated statements of cash flows for the three months ended March 31, 2014 and 2013.
	March 31, 2014 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	43,674		$	20,686		$	64,360
Increase in fair value of Notes receivable – Rights to MSRs	—			(4,025		)	(4,025		)
All other operating cash flows	43,432			—			43,432
Net cash provided by operating activities	87,106			16,661			103,767
Reduction in Notes receivable – Rights to MSRs	16,661			(16,661		)	—
All other investing cash flows	(608,794		)	—			(608,794		)
Net cash used in investing activities	(592,133		)	(16,661		)	(608,794		)
Net cash provided by financing activities	493,051			—			493,051
Net decrease in cash and cash equivalents	(11,976		)	—			(11,976		)
Cash and cash equivalents at beginning of period	87,896			—			87,896
Cash and cash equivalents at end of period	$	75,920		$	—		$	75,920
	March 31, 2013 (Unaudited)
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	24,788		$	3,297		$	28,085
All other operating cash flows	342,306			—			342,306
Net cash provided by operating activities	367,094			3,297			370,391
Reduction in Notes receivable – Rights to MSRs	10,636			(3,297		)	7,339
All other investing cash flows	(814,319		)	—			(814,319		)
Net cash used in investing activities	(803,683		)	(3,297		)	(806,980		)
Net cash provided by financing activities	421,698			—			421,698
Net decrease in cash and cash equivalents	(14,891		)	—			(14,891		)
Cash and cash equivalents at beginning of period	76,048			—			76,048
Cash and cash equivalents at end of period	$	61,157		$	—		$	61,157

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Entity
Business Acquisition [Line Items]	'
Number of variable interest entities which company is the primary beneficiary	3
Mortgage Loans Two | Purchase Agreement	'
Business Acquisition [Line Items]	'
Unpaid principal balance of assets purchased	549,411

Summary_of_Assets_and_Liabilit

Summary of Assets and Liabilities of SPEs (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	$6,343,397		$6,387,781
Loans held for investment	552,644		0
Related party receivables	67,599		70,049
Other assets	192,769		130,153
Total assets	7,871,147		7,310,672
Match funded liabilities	5,775,180		5,715,622
Other borrowings	815,431		343,386
Other liabilities	11,510		11,884
Total liabilities	6,622,447		6,094,225
Variable Interest Entity, Primary Beneficiary	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	6,343,397		6,387,781
Loans held for investment	552,644		0
Related party receivables	56,655	[1]	60,239	[1]
Other assets	182,642	[2]	119,902	[2]
Total assets	7,135,338		6,567,922
Match funded liabilities	5,775,180		5,715,622
Other borrowings	472,734	[3]	0	[3]
Other liabilities	5,745		4,673
Total liabilities	6,253,659		5,720,295
Match Funded Advance SPEs | Variable Interest Entity, Primary Beneficiary	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	6,343,397		6,387,781
Loans held for investment	0		0
Related party receivables	56,655	[1]	60,239	[1]
Other assets	120,980	[2]	119,902	[2]
Total assets	6,521,032		6,567,922
Match funded liabilities	5,775,180		5,715,622
Other borrowings	0	[3]	0	[3]
Other liabilities	4,525		4,673
Total liabilities	5,779,705		5,720,295
Mortgage Loans SPE | Variable Interest Entity, Primary Beneficiary	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	0		0
Loans held for investment	552,644		0
Related party receivables	0	[1]	0	[1]
Other assets	61,662	[2]	0	[2]
Total assets	614,306		0
Match funded liabilities	0		0
Other borrowings	472,734	[3]	0	[3]
Other liabilities	1,220		0
Total liabilities	$473,954		$0
[1]	Related party receivables principally includes Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 14 for more information about our Related party receivables.
[2]	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of the GNMA EBO Transaction. See Note 5 for more information about our Other assets.
[3]	Other borrowings include the carrying value of our Mortgage Loan Facility. See Note 7 for more information about our Other borrowings.

Asset_Acquisitions_Additional_

Asset Acquisitions - Additional Information (Detail) (USD $)	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 03, 2014
In Thousands, unless otherwise specified	agreement	Purchase Agreement	Purchase Agreement	Purchase Agreement	Ocwen
		Mortgage Loans One	Mortgage Loans Two	Purchase Four
Business Acquisition [Line Items]	'	'	'	'	'
Pooling And Servicing Agreements	93	'	'	'	'
Date of additional asset purchase supplement	'	'	'	3-Mar-14	'
Unpaid principal balance of assets purchased	'	$15,900,000	$549,411	'	'
GNMA EBO loans purchase price	'	'	'	'	$556,618	[1]
[1]	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.

Asset_Acquisitions_Summary_of_

Asset Acquisitions - Summary of Purchase Price of Assets and Liabilities (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 03, 2014		Mar. 31, 2013	Mar. 31, 2013		Mar. 31, 2013		Mar. 03, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified			Ocwen		Ocwen	Ocwen		Ocwen		Ocwen	Ocwen
						Mortgage Servicing Rights		Advances To Suppliers		Sources Of Supply	Sources Of Supply
Business Acquisition [Line Items]	'	'	'		'	'		'		'	'
GNMA EBO loans purchase price	'	'	$556,618	[1]	'	'		$814,319	[1]	'	'
Payments to Acquire Businesses, Gross	'	'	'		'	'		'		83,884	153,142
Notes receivable - Rights to MSRs	'	'	'		100,707	'		'		'	'
Match funded advances	'	'	'		'	703,206	[2]	'		'	'
Purchase price	'	'	'		803,913	'		'		'	'
Post-closing adjustments	'	'	'		10,406	'		'		'	'
Match funded liabilities	'	'	'		'	'		'		'	661,177
Other borrowings	$815,431	$343,386	'		'	'		'		$472,734	'
[1]	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.
[2]	The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of residential mortgage assets” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR plus 3.50%
Percentage added for interest rate	3.50%
Minimum	'
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'
Discount rate of risk of earning of future income streams	15.00%
Mortgage loan prepayment rate	12.00%
Mortgage loan delinquency rate	15.00%
Maximum	'
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'
Discount rate of risk of earning of future income streams	22.00%
Mortgage loan prepayment rate	28.00%
Mortgage loan delinquency rate	35.00%

Fair_Value_and_Changes_in_Asse

Fair Value and Changes in Assets and Liabilities Measured on Recurring Basis (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Financial assets:	'		'
Derivative financial instruments	$3,523	[1]	$3,835	[1]
Recurring, Fair Value	'		'
Financial assets:	'		'
Notes receivable - Rights to MSRs	637,794		633,769
Derivative financial instruments	3,523		3,835
Total financial assets	641,317		637,604
Financial liabilities:	'		'
Derivative financial instruments	444		529
Total financial liabilities	444		529
Recurring, Fair Value | Level 3	'		'
Financial assets:	'		'
Notes receivable - Rights to MSRs	637,794		633,769
Derivative financial instruments	3,523	[1]	3,835	[1]
Total financial assets	641,317		637,604
Financial liabilities:	'		'
Derivative financial instruments	444		529
Total financial liabilities	$444		$529
[1]	See Notes 3 and 9 for more information regarding our use of derivatives.

Reconciliation_of_Changes_in_F

Reconciliation of Changes in Fair Value (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Notes Receivable - Rights to MSRs	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Beginning balance	$633,769		$296,451
Purchases and reductions:	'		'
Purchases	0		100,707
Reductions	0		-7,339
Total	0		93,368
Changes in fair value :	'		'
Included in net income	4,025	[1]	0	[1]
Total	4,025		0
Transfers in or out of Level 3	0		0
Ending balance	637,794		389,819
Derivative Financial Instruments	'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'
Beginning balance	3,306		-1,076
Changes in fair value :	'		'
Included in other comprehensive income	-227	[2]	13	[2]
Total	-227		13
Transfers in or out of Level 3	0		0
Ending balance	$3,079		($1,063)
[1]	Changes in fair value of the Notes receivable – Rights to MSRs are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 10 for additional information regarding our Interest income.
[2]	These pre-tax gains (losses) are attributable to derivatives still held at March 31, 2014 and March 31, 2013, respectively.

Effect_on_Fair_Value_of_Note_R

Effect on Fair Value of Note Receivable - Rights to MSRs (Detail) (Notes Receivable - Rights to MSRs, USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Notes Receivable - Rights to MSRs	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate 100 bps adverse change	($12,936)	($12,988)
Prepayment Speeds 10% adverse change	-21,693	-22,537
Delinquency Rates 10% adverse change	($71,773)	($72,560)

Quantitative_Information_on_Si

Quantitative Information on Significant Observable Inputs Used for Valuing Note Receivable - Rights to MSRs (Detail)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Minimum	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	15.00%	'
Prepayment Speeds	12.00%	'
Delinquency Rates	15.00%	'
Maximum	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	22.00%	'
Prepayment Speeds	28.00%	'
Delinquency Rates	35.00%	'
Notes Receivable - Rights to MSRs	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Weighted Average - Discount Rate	19.00%	20.00%
Weighted Average - Prepayment Speeds	18.00%	19.00%
Weighted Average - Delinquency Rates	24.00%	25.00%
Notes Receivable - Rights to MSRs | Minimum	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	'	15.00%
Prepayment Speeds	'	12.00%
Delinquency Rates	'	15.00%
Notes Receivable - Rights to MSRs | Maximum	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	'	22.00%
Prepayment Speeds	'	28.00%
Delinquency Rates	'	35.00%

Carrying_Values_and_Fair_Value

Carrying Values and Fair Value Estimates of Financial Instruments Not Carried at Fair Value (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financial assets:	'	'
Match funded advances	$6,343,397	$6,387,781
Loans held for investment	552,644	0
Financial liabilities:	'	'
Match funded liabilities	5,775,180	5,715,622
Other borrowings	815,431	343,386
Carrying Value	'	'
Financial assets:	'	'
Match funded advances	6,343,397	6,387,781
Loans held for investment	552,644	0
Total financial assets	6,896,041	6,387,781
Financial liabilities:	'	'
Match funded liabilities	5,775,180	5,715,622
Other borrowings	815,431	343,386
Total financial liabilities	6,590,611	6,059,008
Fair Value	'	'
Financial assets:	'	'
Match funded advances	6,343,397	6,387,781
Loans held for investment	552,644	0
Total financial assets	6,896,041	6,387,781
Financial liabilities:	'	'
Match funded liabilities	5,770,270	5,700,934
Other borrowings	817,144	346,391
Total financial liabilities	$6,587,414	$6,047,325

Match_Funded_Advances_on_Resid

Match Funded Advances on Residential Loans (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]	'	'
Match funded advances	$6,343,397	$6,387,781
Variable Interest Entities	'	'
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]	'	'
Principal and interest advances	2,724,333	2,632,092
Taxes and insurance advances	2,665,270	2,723,390
Corporate advances	953,794	1,032,299
Match funded advances	$6,343,397	$6,387,781

Other_Assets_Detail

Other Assets (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'		'
Debt service accounts	$106,987	[1]	$103,910	[1]
Debt issuance costs	22,669	[2]	21,165	[2]
Accrued interest income	2,255	[3]	0	[3]
Interest-earning collateral deposits	1,075	[4]	1,075	[4]
Derivative financial instruments	3,523	[5]	3,835	[5]
Advance financing receivable	55,702	[6]	0	[6]
Other	558		168
Total	$192,769		$130,153
[1]	Under our advance funding facilities, we are contractually required to remit collections on Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest.
[2]	Costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
[3]	Represents accrued interest income on our GNMA EBO loans and interest earned on our financing of GNMA EBO advances. The GNMA EBO loans remain on accrual status as collection is reasonably assured. GNMA EBO advance financing interest income is settled on a monthly basis.
[4]	Represents cash collateral held by our counterparty as part of our interest rate swap agreements.
[5]	See Notes 3 and 9 for more information regarding our use of derivatives.
[6]	We provided financing to Ocwen for GNMA EBO advances as part of the GNMA EBO Transaction. We accounted for this as a financing transaction and receive interest income at a rate of 1- Month LIBOR plus 450 bps.

Other_Assets_Parenthetical_Det

Other Assets (Parenthetical) (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Period to remit collections on pledged advances to the trustee	'2 days	'
Proceeds from loans held for investment	$3,526	$0
LIBOR	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Basis points added to 1-Month LIBOR	4.50%	'
Financing receivable, variable rate	'1- Month LIBOR	'

Match_Funded_Liabilities_Detai

Match Funded Liabilities (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Dec. 31, 2013
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.50%		'
Ending Balance	$5,775,180		$5,715,622
Variable Interest Entities	'		'
Debt Instrument [Line Items]	'		'
Unused borrowing capacity	818,320	[1],[2]	'
Ending Balance	5,775,180	[1],[3]	5,715,622	[1]
Variable Interest Entities | Series 2012 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'199 – 494 bps	[1],[4]	'
Debt instrument, maturity date	1-Oct-45	[1],[5]	'
Debt instrument, amortization date	'2015-10	[1],[5]	'
Ending Balance	450,000	[1],[3]	450,000	[1]
Variable Interest Entities | Series 2012 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.99%		'
Variable Interest Entities | Series 2012 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	4.94%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 1	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'90 – 249 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-44	[1],[5]	'
Debt instrument, amortization date	'2014-01	[1],[5]	'
Ending Balance	0	[1],[3]	650,000	[1]
Variable Interest Entities | Series 2013 T1 Term Notes | Group 1 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	0.90%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 1 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.49%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 2	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'150 – 323 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-46	[1],[5]	'
Debt instrument, amortization date	'2016-01	[1],[5]	'
Ending Balance	350,000	[1],[3]	350,000	[1]
Variable Interest Entities | Series 2013 T1 Term Notes | Group 2 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.50%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 2 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.23%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 3	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'229 – 446 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-48	[1],[5]	'
Debt instrument, amortization date	'2018-01	[1],[5]	'
Ending Balance	150,000	[1],[3]	150,000	[1]
Variable Interest Entities | Series 2013 T1 Term Notes | Group 3 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.29%		'
Variable Interest Entities | Series 2013 T1 Term Notes | Group 3 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	4.46%		'
Variable Interest Entities | Series 2013 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'115 – 239 bps	[1],[4]	'
Debt instrument, maturity date	1-May-44	[1],[5]	'
Debt instrument, amortization date	'2015-05	[1],[5]	'
Ending Balance	375,000	[1],[3]	375,000	[1]
Variable Interest Entities | Series 2013 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.15%		'
Variable Interest Entities | Series 2013 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.39%		'
Variable Interest Entities | Series 2013 T3 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'179 – 313 bps	[1],[4]	'
Debt instrument, maturity date	1-May-46	[1],[5]	'
Debt instrument, amortization date	'2017-05	[1],[5]	'
Ending Balance	475,000	[1],[3]	475,000	[1]
Variable Interest Entities | Series 2013 T3 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.79%		'
Variable Interest Entities | Series 2013 T3 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.13%		'
Variable Interest Entities | Series 2013 T4 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'118 – 232 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-44	[1],[5]	'
Debt instrument, amortization date	'2014-08	[1],[5]	'
Ending Balance	200,000	[1],[3]	200,000	[1]
Variable Interest Entities | Series 2013 T4 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.18%		'
Variable Interest Entities | Series 2013 T4 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.32%		'
Variable Interest Entities | Series 2013 T5 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'198 – 331 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-46	[1],[5]	'
Debt instrument, amortization date	'2016-08	[1],[5]	'
Ending Balance	200,000	[1],[3]	200,000	[1]
Variable Interest Entities | Series 2013 T5 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.98%		'
Variable Interest Entities | Series 2013 T5 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.31%		'
Variable Interest Entities | Series 2013 T6 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'129 – 223 bps	[1],[4]	'
Debt instrument, maturity date	1-Sep-44	[1],[5]	'
Debt instrument, amortization date	'2014-09	[1],[5]	'
Ending Balance	350,000	[1],[3]	350,000	[1]
Variable Interest Entities | Series 2013 T6 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.29%		'
Variable Interest Entities | Series 2013 T6 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.23%		'
Variable Interest Entities | Series 2013 T7 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'198 – 302 bps	[1],[4]	'
Debt instrument, maturity date	1-Nov-46	[1],[5]	'
Debt instrument, amortization date	'2016-11	[1],[5]	'
Ending Balance	300,000	[1],[3]	300,000	[1]
Variable Interest Entities | Series 2013 T7 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.98%		'
Variable Interest Entities | Series 2013 T7 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.02%		'
Variable Interest Entities | Series 2014 T1 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'124 – 229 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-45	[1],[5]	'
Debt instrument, amortization date	'2015-01	[1],[5]	'
Ending Balance	600,000	[1],[3]	0	[1]
Variable Interest Entities | Series 2014 T1 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.24%		'
Variable Interest Entities | Series 2014 T1 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.29%		'
Variable Interest Entities | Series 2014 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'222 – 311 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-47	[1],[5]	'
Debt instrument, amortization date	'2017-01	[1],[5]	'
Ending Balance	200,000	[1],[3]	0	[1]
Variable Interest Entities | Series 2014 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.22%		'
Variable Interest Entities | Series 2014 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.11%		'
Variable Interest Entities | Series 2012 VF 1 Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-44	[1],[5]	'
Debt instrument, amortization date	'2014-08	[1],[5]	'
Unused borrowing capacity	255,524	[1],[2]	'
Ending Balance	444,476	[1],[3]	469,050	[1]
Variable Interest Entities | Series 2012 VF 1 Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entities | Series 2012 VF 1 Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entities | Series 2012 VF 2 Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-44	[1],[5]	'
Debt instrument, amortization date	'2014-08	[1],[5]	'
Unused borrowing capacity	255,524	[1],[2]	'
Ending Balance	444,476	[1],[3]	469,050	[1]
Variable Interest Entities | Series 2012 VF 2 Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entities | Series 2012 VF 2 Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entities | Series 2013 VF 3 Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-44	[1],[5]	'
Debt instrument, amortization date	'2014-08	[1],[5]	'
Unused borrowing capacity	255,524	[1],[2]	'
Ending Balance	444,476	[1],[3]	469,050	[1]
Variable Interest Entities | Series 2013 VF 3 Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entities | Series 2013 VF 3 Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entities | Series 2013 VF 1 Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 150 - 245 bps	[1],[4],[6]	'
Debt instrument, maturity date	1-Feb-45	[1],[5],[6]	'
Debt instrument, amortization date	'2015-02	[1],[5],[6]	'
Unused borrowing capacity	51,748	[1],[2],[6]	'
Ending Balance	498,252	[1],[3],[6]	514,972	[1],[6]
Variable Interest Entities | Series 2013 VF 1 Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.50%		'
Variable Interest Entities | Series 2013 VF 1 Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	2.45%		'
Variable Interest Entities | Class A Term Money Market Fund Note	'		'
Debt Instrument [Line Items]	'		'
Interest rate	0.20%		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 20 bps	[1],[4],[7]	'
Debt instrument, maturity date	1-Sep-14	[1],[5],[7]	'
Debt instrument, amortization date	'2014-01	[1],[5],[7]	'
Ending Balance	176,667	[1],[3],[7]	265,000	[1],[7]
Variable Interest Entities | Class A Draw Money Market Fund Note	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 bps	[1],[4],[7]	'
Debt instrument, maturity date	1-Sep-44	[1],[5],[7]	'
Debt instrument, amortization date	'2014-09	[1],[5],[7]	'
Ending Balance	88,333	[1],[3],[7]	0	[1],[7]
Variable Interest Entities | Class B Term Money Market Fund Note	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.75%		'
Interest rate to calculate the cost of servicing advances	'275 bps	[1],[4]	'
Debt instrument, maturity date	1-Sep-44	[1],[5]	'
Debt instrument, amortization date	'2014-09	[1],[5]	'
Ending Balance	$28,500	[1],[3]	$28,500	[1]
[1]	Each term note and variable funding note issuance has four classes, an A, B, C, and D class.
[2]	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity which varies by facility.
[3]	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes.
[4]	The weighted average interest rate at March 31, 2014 was 1.68%. We pay interest monthly.
[5]	The amortization date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
[6]	These Variable Funding Notes were amended on February 14, 2014, to extend the amortization and maturity dates by a year and to reduce the interest rate spreads compared to December 31, 2013. Variable Funding Note balances fluctuate based on Match funded advance activity and our ability to issue fixed rate term notes.
[7]	The Class A Term Money Market Fund Note and Class A Draw Money Market Fund Note have a combined maximum borrowing capacity of $265,000. By design, the Class A Term Money Market Fund Note balance is reduced at scheduled times and there is an equally offsetting increase to the Class A Draw Money Market Fund Note. The combined balance of these notes was equal to $265,000 at March 31, 2014 and December 31, 2013. The amortization date for the Class A Term Money Market Fund Note represents the commencement date for scheduled repayments.

Match_Funded_Liabilities_Paren

Match Funded Liabilities (Parenthetical) (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Jan. 17, 2014	Jan. 17, 2014
			Minimum	Maximum	One-Year Term Notes	Three-Year Term Notes
Debt Instrument [Line Items]	'	'	'	'	'	'
Weighted average interest rate	1.68%	'	'	'	'	'
Percentage of fee on the unused borrowing	'	'	0.50%	0.63%	'	'
Debt instrument issuance	'	'	'	'	$600,000,000	$200,000,000
Maturity period for note	'	'	'	'	'1 year	'3 years
Combined maximum borrowing capacity	$265,000,000	$265,000,000	'	'	'	'

Analysis_of_Borrowing_by_Matur

Analysis of Borrowing by Maturity (Detail) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified
Analysis of Borrowing by Expected Maturity:	'
2014	$2,176,928	[1]
2015	1,923,252	[1]
2016	850,000	[1]
2017	675,000	[1]
2018 and thereafter	150,000	[1]
Total	$5,775,180	[1]
[1]	(1)The expected maturity date is the date on which the revolving period ends under each Advance Facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.

Other_Borrowings_Detail

Other Borrowings (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'		'
Weighted average interest rate for other borrowings	3.75%		'
Other borrowings	$815,431		$343,386
Senior Secured Term Loan Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	342,697	[1]	343,386	[1]
Mortgage Loan Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	$472,734	[1]	$0	[1]
[1]	On June 27, 2013, we entered into a $350,000 senior secured term loan facility which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of March 31, 2014, the interest rate on our senior secured term loan facility was 4.50%.

Other_Borrowings_Parenthetical

Other Borrowings (Parenthetical) (Detail) (USD $)

3 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

Mar. 31, 2014

Dec. 31, 2013

Jun. 27, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 03, 2014

Mar. 31, 2014

Jun. 27, 2013

Jun. 27, 2013

Mar. 03, 2014

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Mortgage Loan Facility

Mortgage Loan Facility

Revolving Credit Facility

Revolving Credit Facility

Base Rate

LIBOR

LIBOR

Mortgage Loan Facility

Mortgage Loan Facility

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Revolving Credit Facility

Mortgage Loan Facility

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument face amount

'

'

$350,000,000

'

'

'

'

'

'

'

'

'

Debt instrument, maturity date

'

'

27-Jun-20

'

'

'

'

'

'

'

'

'

Interest rate, description

'

'

'an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor

'

'

'

'

'1- Month LIBOR

'

'

'

'

Percentage added for interest rate

3.50%

'

'

'

'

'

'

'

'

3.50%

'

3.05%

Floor of LIBOR

'

'

'

'

'

'

'

'

'

'

1.00%

'

Debt instrument, interest rate

'

'

'

4.50%

'

'

'

'

'

'

'

'

Debt instrument carrying amount

815,431,000

343,386,000

'

342,697,000

[1]

343,386,000

[1]

472,734,000

[1]

0

[1]

'

'

'

'

'

Maximum borrowing capacity

265,000,000

265,000,000

'

'

'

'

'

600,000,000

'

'

'

'

Unused borrowing capacity

'

'

'

'

'

'

'

'

$127,266,000

'

'

'

[1]

On June 27, 2013, we entered into a $350,000 senior secured term loan facility which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of March 31, 2014, the interest rate on our senior secured term loan facility was 4.50%.

Analysis_of_Borrowing_by_Matur1

Analysis of Borrowing by Maturity - Senior Secured Term Loan Facility (Detail) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified
Analysis of Other Borrowing by Expected Repayment Date:	'
2014	$2,625	[1]
2015	476,234	[1]
2016	3,500	[1]
2017	3,500	[1]
2018 and thereafter	334,250	[1]
Total	$820,109	[1]
[1]	The Mortgage Loan Facility expected payment date is based on the current outstanding balance and maturity date of the facility.

Increases_in_Number_of_Ordinar

Increases in Number of Ordinary Shares (Detail)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Equity [Abstract]	'	'
Ordinary shares issued - beginning balance	71,016,771	55,884,718
Issuance of new ordinary shares	0	970,578
Ordinary shares issued - ending balance	71,016,771	56,855,296

Ordinary_Shares_Additional_Inf

Ordinary Shares - Additional Information (Detail) (USD $)	3 Months Ended		0 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Jan. 22, 2013
			Underwriters Exercise Of Overallotment Option
Subsidiary, Sale of Stock [Line Items]	'	'	'
Number of ordinary shares issued	0	970,578	970,578
Net proceeds from over allotment exercise	$0	$17,633	$17,633
Proceeds from additional shares issued to underwriters	$0	$17,579	'

Derivative_Financial_Instrumen2

Derivative Financial Instruments - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
In Thousands, unless otherwise specified	Cash Flow Hedging	Cash Flow Hedging	Interest Rate Swap
Derivatives, Fair Value [Line Items]	'	'	'
Interest rate swaps to hedge against the effects of a change	'	'	'1-Month LIBOR
Cash collateral right to reclaim of hedge agreements	$1,075	$1,075	'
Cash collateral obligated to return of hedge agreements	$3,510	$3,500	'

Interest_Rate_Swaps_Detail

Interest Rate Swaps (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Dec. 31, 2013
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	$479,058		$515,065
Total asset derivatives, Fair Value	3,523		3,835
Total liability derivatives, Notional Amount	329,200		438,130
Total liability derivatives, Fair Value	444		529
Designated as Hedges	'		'
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	479,058		515,065
Total liability derivatives, Notional Amount	329,200		438,130
Total asset derivatives, Fair Value	3,523		3,835
Total liability derivatives, Fair Value	444		529
Designated as Hedges | Other Liabilities | Interest Rate Swap 1	'		'
Derivatives, Fair Value [Line Items]	'		'
Total liability derivatives, Notional Amount	96,927	[1],[2]	102,522	[1],[2]
Total liability derivatives, Fair Value	343	[1],[2]	364	[1],[2]
Date Opened	15-Mar-12	[1],[2]	15-Mar-12	[1],[2]
Effective Date	15-Mar-12	[1],[3]	15-Mar-12	[1],[3]
Maturity	15-Mar-16	[1],[2]	15-Mar-16	[1],[2]
We Pay	0.63%	[1],[2]	0.63%	[1],[2]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1],[2]
Designated as Hedges | Other Liabilities | Interest Rate Swap 2	'		'
Derivatives, Fair Value [Line Items]	'		'
Total liability derivatives, Notional Amount	25,225	[1],[2]	28,565	[1],[2]
Total liability derivatives, Fair Value	15	[1],[2]	25	[1],[2]
Date Opened	15-May-12	[1],[2]	15-May-12	[1],[2]
Effective Date	15-May-12	[1],[3]	15-May-12	[1],[3]
Maturity	15-May-16	[1],[2]	15-May-16	[1],[2]
We Pay	0.61%	[1],[2]	0.61%	[1],[2]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1],[2]
Designated as Hedges | Other Liabilities | Interest Rate Swap 3	'		'
Derivatives, Fair Value [Line Items]	'		'
Total liability derivatives, Notional Amount	207,048	[1],[2]	307,043	[1],[2]
Total liability derivatives, Fair Value	86	[1],[2]	140	[1],[2]
Date Opened	15-Jan-13	[1],[2]	15-Jan-13	[1],[2]
Effective Date	15-Jan-14	[1],[3]	15-Jan-14	[1],[3]
Maturity	15-Jul-14	[1],[2]	15-Jul-14	[1],[2]
We Pay	0.34%	[1],[2]	0.34%	[1],[2]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1],[2]
Designated as Hedges | Other Assets | Interest Rate Swap 3	'		'
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	141,049	[1],[2]	177,056	[1]
Total asset derivatives, Fair Value	1,079	[1],[2]	1,084	[1]
Date Opened	15-Sep-12	[1],[2]	15-Sep-12	[1]
Effective Date	15-Sep-12	[1],[2]	15-Sep-12	[1],[3]
Maturity	15-Aug-17	[1],[2]	15-Aug-17	[1]
We Pay	0.52%	[1],[2]	0.52%	[1]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1]
Designated as Hedges | Other Assets | Interest Rate Swap 5	'		'
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	338,009	[1],[2]	338,009	[1]
Total asset derivatives, Fair Value	$2,444	[1],[2]	$2,751	[1]
Date Opened	15-Jan-13	[1],[2]	15-Jan-13	[1]
Effective Date	15-Jan-16	[1],[2]	15-Jan-16	[1],[3]
Maturity	15-Dec-17	[1],[2]	15-Dec-17	[1]
We Pay	1.40%	[1],[2]	1.40%	[1]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1]
[1]	There was an unrealized pre-tax loss of $227 related to our interest rate swaps included in AOCI for the three months ended March 31, 2014, and an unrealized pre-tax gain of $13 related to our interest rate swaps included in AOCI for the three months ended March 31, 2013. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
[2]	Projected net settlements for the next twelve months total approximately $1,033 of payments to the counterparty.
[3]	The effective date of the swap is the date from which monthly net settlements begin to be computed.

Interest_Rate_Swaps_Parentheti

Interest Rate Swaps (Parenthetical) (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'
Projected cash flow hedge	$1,033	'
Unrealized gains (losses) related to interest rate swap included in other comprehensive income	($227)	$13

Summarization_of_Use_of_Deriva

Summarization of Use of Derivative (Detail) (Interest Rate Swap, USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Interest Rate Swap	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional beginning balance	$953,195	$414,631
Additions	0	645,052
Maturities	0	0
Terminations	0	0
Amortization	144,937	33,631
Notional ending balance	$808,258	$1,026,052

Calculation_of_Interest_Income

Calculation of Interest Income on Notes Receivable (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Other Income and Expenses [Abstract]	'	'
Servicing fees collected	$189,157	$102,258
Subservicing fee payable to Ocwen	-90,644	-47,052
Net servicing fees retained by HLSS	98,513	55,206
Reduction in Notes receivable - Rights to MSRs	0	-7,339
Increase in fair value of Notes receivable – Rights to MSRs	4,025	0
Total	$102,538	$47,867

Interest_Income_Other_Detail

Interest Income Other (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Interest and Other Income [Line Items]	'		'
Interest income other	$2,961		$102
Loan Interest	'		'
Interest and Other Income [Line Items]	'		'
Interest income other	1,784	[1]	0	[1]
Advance Financing Interest	'		'
Interest and Other Income [Line Items]	'		'
Interest income other	202	[2]	0	[2]
Bank Account Interest	'		'
Interest and Other Income [Line Items]	'		'
Interest income other	$975		$102
[1]	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO loans using the interest method of accounting.
[2]	Represents interest earned on advance financing we provided to Ocwen in connection with their role as a servicer of agency loans.

Components_of_Interest_Expense

Components of Interest Expense (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Interest Expense [Abstract]	'	'
Match funded liabilities	$26,830	$14,781
Other borrowings	5,323	0
Amortization of debt issuance costs	4,962	3,106
Interest rate swaps	396	355
Interest expense	$37,511	$18,242

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Tax Disclosure [Abstract]	'	'
Effective income tax rate	0.00%	0.10%

Business_Segment_Reporting_Add

Business Segment Reporting - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014
	Segment
Segment Reporting [Abstract]	'
Reportable business segment	1

Transactions_with_Ocwen_under_

Transactions with Ocwen under Purchase Agreement (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Related Party Transactions [Abstract]	'	'
Servicing fees collected	$189,157	$102,258
Subservicing fee payable to Ocwen	90,644	47,052
Net servicing fees retained by HLSS	98,513	55,206
Reduction in Notes receivable - Rights to MSRs	0	7,339
Increase in fair value of Notes receivable – Rights to MSRs	4,025	0
Total	102,538	47,867
Servicing advances purchased from Ocwen in the ordinary course of business	$3,503,375	$695,105

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)	3 Months Ended						3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014		Dec. 31, 2013		Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
			Ocwen		Ocwen		Altisource	Altisource	Loan Interest	Loan Interest	Advance Financing Interest
									Ocwen	Ocwen	Ocwen
Related Party Transaction [Line Items]	'	'	'		'		'	'	'	'	'
Servicing fees not yet remitted	'	'	$8,087	[1]	$8,482	[1]	'	'	'	'	'
Subservicing fee owed to Ocwen	'	'	3,738	[2]	8,114	[2]	'	'	'	'	'
Receivables from Ocwen	'	'	67,599		70,049		'	'	2,053	'	202
Interest income	'	'	'		'		'	'	1,986	0	'
Additional markup on actual cost incurred	'	'	15.00%		'		15.00%	'	'	'	'
Service fees with related parties	1,284	'	'		'		'	'	'	'	'
Professional services fee earned	628	407	'		'		'	'	'	'	'
Professional services fee incurred	$154	$30	'		'		$218	$196	'	'	'
[1]	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at March 31, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 10.
[2]	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Receivable_from_and_Payable_to

Receivable from and Payable to Related Parties (Detail) (USD $)	Mar. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Related Party Transaction [Line Items]	'		'
Advance collections	$67,599		$70,049
Advances made	7,885		10,732
Ocwen	'		'
Related Party Transaction [Line Items]	'		'
Servicing fees collected	8,087	[1]	8,482	[1]
Professional services	1,284	[2]	655	[2]
Advance collections	56,655	[3]	60,239	[3]
Other	1,573		673
Receivables from Ocwen	67,599		70,049
Subservicing fees payable	3,738	[4]	8,114	[4]
Professional services	508	[2]	354	[2]
Other	3,621		2,181
Payables to related party	7,867		10,649
Altisource	'		'
Related Party Transaction [Line Items]	'		'
Payables to related party	$18		$83
[1]	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at March 31, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 10.
[2]	The respective amounts are for professional services provided that were receivable as of the dates indicated.
[3]	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
[4]	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Receivable_from_and_Payable_to1

Receivable from and Payable to Related Parties (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2014
Related Party Transaction [Line Items]	'
Period for related party to remit collections	'2 days
Ocwen	'
Related Party Transaction [Line Items]	'
Period to forward servicing fees collected on the Company's behalf by Ocwen	'3 days

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)	3 Months Ended		0 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Apr. 10, 2014	Apr. 17, 2014
			Subsequent Event	Subsequent Event
			Dividend Paid	Dividend Declared
Subsequent Event [Line Items]	'	'	'	'
Dividends paid, cash	$31,958	$20,920	$10,653	'
Cash dividend per share	'	'	$0.15	'
Monthly dividend declared	'	'	'	$0.16

Restatement_Details

Restatement (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]	'	'	'	'
Notes receivable – Rights to MSRs	$637,794,000	'	$633,769,000	'
All other assets	7,233,353,000	'	6,676,903,000	'
Total assets	7,871,147,000	'	7,310,672,000	'
Total liabilities	6,622,447,000	'	6,094,225,000	'
Retained earnings	35,915,000	'	3,513,000	'
All other equity	1,212,785,000	'	1,212,934,000	'
Total equity	1,248,700,000	897,451,000	1,216,447,000	873,379,000
Total liabilities and equity	7,871,147,000	'	7,310,672,000	'
Income Statement [Abstract]	'	'	'	'
Interest income – notes receivable – Rights to MSRs	102,538,000	47,867,000	'	'
Interest income – other	2,961,000	102,000	'	'
Total interest income	105,499,000	47,969,000	'	'
Related party revenue	628,000	407,000	'	'
Total revenue	106,127,000	48,376,000	'	'
Operating expenses	4,256,000	2,037,000	'	'
Income from operations	101,871,000	46,339,000	'	'
Other expense	'	'	'	'
Interest expense	37,511,000	18,242,000	'	'
Total other expense	37,511,000	18,242,000	'	'
Income before income taxes	64,360,000	28,097,000	'	'
Income tax expense	0	12,000	'	'
Net income	64,360,000	28,085,000	'	'
Earnings per share	'	'	'	'
Earnings per share (usd per share)	$0.91	$0.50	'	'
Diluted earnings per share (usd per share)	$0.91	$0.50	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'
Total other comprehensive loss, before tax	-227,000	13,000	'	'
Tax benefit on other comprehensive loss	78,000	0	'	'
Total other comprehensive income (loss), net of tax	-149,000	13,000	'	'
Total comprehensive income	64,211,000	28,098,000	'	'
Statement of Cash Flows [Abstract]	'	'	'	'
Increase in the fair value of Notes receivable – Rights to MSRs	-4,025,000	0	'	'
All other operating cash flows	43,432,000	342,306,000	'	'
Net cash provided by operating activities	103,767,000	370,391,000	'	'
Reduction in notes receivable – Rights to MSRs	0	7,339,000	'	'
All other investing cash flows	-608,794,000	-814,319,000	'	'
Net cash used in investing activities	-608,794,000	-806,980,000	'	'
Net cash provided by financing activities	493,051,000	421,698,000	'	'
Net (decrease) in cash	-11,976,000	-14,891,000	'	'
Cash at beginning of period	87,896,000	76,048,000	'	'
Cash at end of period	75,920,000	61,157,000	'	'
As Previously Reported	'	'	'	'
Statement of Financial Position [Abstract]	'	'	'	'
Notes receivable – Rights to MSRs	634,399,000	'	651,060,000	'
All other assets	7,233,353,000	'	6,676,903,000	'
Total assets	7,867,752,000	'	7,327,963,000	'
Total liabilities	6,622,447,000	'	6,094,225,000	'
Retained earnings	32,520,000	'	20,804,000	'
All other equity	1,212,785,000	'	1,212,934,000	'
Total equity	1,245,305,000	'	1,233,738,000	'
Total liabilities and equity	7,867,752,000	'	7,327,963,000	'
Income Statement [Abstract]	'	'	'	'
Interest income – notes receivable – Rights to MSRs	81,852,000	44,570,000	'	'
Interest income – other	2,961,000	102,000	'	'
Total interest income	84,813,000	44,672,000	'	'
Related party revenue	628,000	407,000	'	'
Total revenue	85,441,000	45,079,000	'	'
Operating expenses	4,256,000	2,037,000	'	'
Income from operations	81,185,000	43,042,000	'	'
Other expense	'	'	'	'
Interest expense	37,511,000	18,242,000	'	'
Total other expense	37,511,000	18,242,000	'	'
Income before income taxes	43,674,000	24,800,000	'	'
Income tax expense	0	12,000	'	'
Net income	43,674,000	24,788,000	'	'
Earnings per share	'	'	'	'
Earnings per share (usd per share)	$0.61	$0.44	'	'
Diluted earnings per share (usd per share)	$0.61	$0.44	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'
Total other comprehensive loss, before tax	-227,000	13,000	'	'
Tax benefit on other comprehensive loss	78,000	0	'	'
Total other comprehensive income (loss), net of tax	-149,000	13,000	'	'
Total comprehensive income	43,525,000	24,801,000	'	'
Statement of Cash Flows [Abstract]	'	'	'	'
Increase in the fair value of Notes receivable – Rights to MSRs	0	'	'	'
All other operating cash flows	43,432,000	342,306,000	'	'
Net cash provided by operating activities	87,106,000	367,094,000	'	'
Reduction in notes receivable – Rights to MSRs	16,661,000	10,636,000	'	'
All other investing cash flows	-608,794,000	-814,319,000	'	'
Net cash used in investing activities	-592,133,000	-803,683,000	'	'
Net cash provided by financing activities	493,051,000	421,698,000	'	'
Net (decrease) in cash	-11,976,000	-14,891,000	'	'
Cash at beginning of period	87,896,000	76,048,000	'	'
Cash at end of period	75,920,000	61,157,000	'	'
Adjustments	'	'	'	'
Statement of Financial Position [Abstract]	'	'	'	'
Notes receivable – Rights to MSRs	3,395,000	'	-17,291,000	'
All other assets	0	'	0	'
Total assets	3,395,000	'	-17,291,000	'
Total liabilities	0	'	0	'
Retained earnings	3,395,000	'	-17,291,000	'
All other equity	0	'	0	'
Total equity	3,395,000	'	-17,291,000	'
Total liabilities and equity	3,395,000	'	-17,291,000	'
Income Statement [Abstract]	'	'	'	'
Interest income – notes receivable – Rights to MSRs	20,686,000	3,297,000	'	'
Interest income – other	0	0	'	'
Total interest income	20,686,000	3,297,000	'	'
Related party revenue	0	0	'	'
Total revenue	20,686,000	3,297,000	'	'
Operating expenses	0	0	'	'
Income from operations	20,686,000	3,297,000	'	'
Other expense	'	'	'	'
Interest expense	0	0	'	'
Total other expense	0	0	'	'
Income before income taxes	20,686,000	3,297,000	'	'
Income tax expense	0	0	'	'
Net income	20,686,000	3,297,000	'	'
Earnings per share	'	'	'	'
Earnings per share (usd per share)	$0.30	$0.06	'	'
Diluted earnings per share (usd per share)	$0.30	$0.06	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'
Total other comprehensive loss, before tax	0	0	'	'
Tax benefit on other comprehensive loss	0	0	'	'
Total other comprehensive income (loss), net of tax	0	0	'	'
Total comprehensive income	20,686,000	3,297,000	'	'
Statement of Cash Flows [Abstract]	'	'	'	'
Increase in the fair value of Notes receivable – Rights to MSRs	-4,025,000	'	'	'
All other operating cash flows	0	0	'	'
Net cash provided by operating activities	16,661,000	3,297,000	'	'
Reduction in notes receivable – Rights to MSRs	-16,661,000	-3,297,000	'	'
All other investing cash flows	0	0	'	'
Net cash used in investing activities	-16,661,000	-3,297,000	'	'
Net cash provided by financing activities	0	0	'	'
Net (decrease) in cash	0	0	'	'
Cash at beginning of period	0	0	'	'
Cash at end of period	$0	$0	'	'